The mammalian host defense is categorized into innate and adaptive immunity (1,2,3). Host defense relies on a concerted action of both antigen (Ag)-nonspecific innate immunity and Ag-specific adaptive immunity (4–6).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ezekowitz, R. A. B. and Hoffmann, J. A. (eds.) (2003) Innate Immunity, Humana Press, Totowa, NJ
Gordon, S. (2003) Mammalian host defenses. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A. eds.), Humana Press, Totowa, NJ, pp. 175–176
Kaisho, T. and Akira, S. (2003) Toll-like receptors. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A. eds.), Humana Press, Totowa, NJ, pp. 177–189
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., and Palucka, K. (2000) Immunobiology of dendritic cells, Annu. Rev. Immunol., 18, 767–811
Fearon, D.T. and Locksley, R. M. (1996) The instructive role of innate immunity in the acquired immune response, Science, 272, 50–53
Hoffmann, J.A., Kafatos, F. C., Janeway, C. A., and Ezekowitz, R. A. (1999) Phylogenetic perspectives in innate immunity, Science, 284, 1313–1318
Kunkel, S. L. (2003) Mamalian host defenses: links between innate and adaptive immunity. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A. eds.), Humana Press, Totowa, NJ, pp. 267–268
Ramkumar, T. P., Hammache, D., and Stahl, P. D. (2003) The macrophage mannose receptor and innate immunity. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A. eds.), Humana Press, Totowa, NJ, pp. 191–204
Janeway, C. A., Jr. (1992) The immune system evolved to discriminate infectious nonself from noninfectious self, Immunol. Today, 13, 11–16
Aderem, A. and Ulevitch, R. J. (2000) Toll-like receptors in the induction of the innate immune response, Nature, 406, 782–787
Akira, S., Takeda, K., and Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity, Nat. Immunol., 2, 675–680
Hogaboam, C. M. and Kunkel, S. L. (2003) The role of chemokines in linking innate and adaptive immunity. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A. eds.), Humana Press, Totowa, NJ, pp. 269–286
Palucka, K. and Banchereau, J. (1999) Linking innate and adaptive immunity, Nat. Med., 5, 868–870
Bromley, S. K., Burack, W. R., Johnson, K. G., et al. (2001) The immunological synapse, Annu. Rev. Immunol., 19, 375–369
Parish, C. R. and O’Neill, E. R. (1997) Dependence of the adaptive immune response on innate immunity: some questions answered but new paradoxes emerge, Immunol. Cell Biol., 75, 523–527
Lo, D., Feng, L., Li, L., et al. (1999) Integrating innate and adaptive immunity in the whole animal, Immunol. Rev., 169, 225–239
Takeda, K., Kaisho, T., and Akira, S. (2003) Toll-like receptors, Annu. Rev. Immunol., 21, 335–376
Tanji, T., Hu, X., Weber, A. N. R., and Ip, Y. Y. (2007) Toll and IMD pathways synergistically activate an innate immune response in Drosophila melanogaster, Mol. Cell Biol., 27(12), 4578–4588
Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., and Bazan, J. F. (1998) A family of human receptors structurally related to Drosophila Toll, Proc. Natl. Acad. Sci. U.S.A., 95, 588–593
Takeuchi, O., Kawai, T., Sanjo, H., et al. (1999) TLR6: a novel member of an expanding Toll-like receptor family, Gene, 231, 59–65
Du, X., Poltorak, A., Wei, Y., and Beutler, B. (2000) Three novel mammalian Toll-like receptors: gene structure, expression, and evolution, Eur. Cytokine Netw., 11, 362–371
Hemmi, H., Takeuchi, O., Kawai, T., et al. (2000) Toll-like receptor recognizes bacterial DNA, Nature, 408, 740–745
Chuang, T. and Ulevitch, R. J. (2001) Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells, Biochim. Biophys. Acta, 1518(1–2), 157–161
Takeda, K. and Akira, S. (2004) TLR signaling pathways, Semin. Immunol., 16(1), 3–9
Underhill, D. M., Ozinsky, A., Smith, K. D., and Aderem, A. (1999) Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages, Proc. Natl. Acad. Sci. U.S.A., 96, 14459–14463
Steiner, T. S., Nataro, J. P., Poteet-Smith, C. E., Smith, J. A., and Guerrant, R. L. (2000) Enteroaggregative Escheria coli express a novel flagellin that caused IL-8 release from intestinal epithelial cells, J. Clin. Invest., 105, 1769–1777
Eaves-Pyles, T., Murthy, K., Liaudet, L., et al. (2001) Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IҝBα degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction, J. Immunol., 166, 1248–1260
Hayashi, F., Smith, K. D., Ozinsky, A., et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor-5, Nature, 410, 1099–1103
Gewirtz, A. T., Simon, J., Schmitt, C. K., et al. (2001) Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response, J. Clin. Invest., 107, 99–109
Tokunaga, T., Yamamoto, H., Shimada, S., et al. (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity, J. Natl. Cancer Inst., 72, 955–962
Krieg, A. M., Yi, A. K., Matson, S., et al. (1995) CpG motifs in bacterial DNA trigger direct B cell activation, Nature, 374, 546–549
Stahl, P. D. and Ezekowitz, R. A. (1998) The mannose receptor is a pattern recognition receptor involved in host defense, Curr. Opin. Immunol., 10, 50–55
Linehan, S. A., Martinez-Pomares, L., and Gordon, S. (2000) Macrophage lectins in host defence, Microbes Infect., 2, 279–288
Taylor, M. E. (2001) Structure and function of the macrophage mannose receptor, Results Probl. Cell Differ., 33, 105–121
Medzhitov, R. and Janeway, C. A., Jr. (1997) Innate immunity: impact on the adaptive immune response, Curr. Opin. Immunol., 9, 4–9
Hille-Rehfeld, A. (1995) Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes, Biochim. Biophys. Acta, 1241, 177–194
Stahl, P. D., Wileman, T. E., Diment, S., and Shepherd, V. L. (1984) Mannose- specific oligosaccharide recognition by monomeric phagocytes, Biol. Cell, 51, 215–218
Martinez-Pomares, L., Mahoney, J. A., Kaposzta, R., et al. (1998) A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum, J. Biol. Chem., 273, 23376–23380
Martinez-Pomares, L. and Gordon, S. (1999) Potential role of the mannose receptor in antigen transport, Immunol. Lett., 65, 9–13
Schweizer, A., Stahl, P. D., and Rohrer, J. (2000) A di-aromatic motif in the cytosolic tail of the mannose receptor mediates endosomal sorting, J. Biol. Chem., 275, 29694–29700
Kruskal, B. A., Sastry, K., Warner, A. B., Mathieu, C. E., and Ezekowitz, R. A. (1992) Phagocytic chimeric receptors require both transmembrane and cytoplasmic domains from the mannose receptor, J. Exp. Med., 176, 1673–1680
Pontow, S. E., Blum, J. S., and Stahl, P. D. (1996) Delayed activation of the mannose receptor following synthesis. Requirement for exit from the endoplasmic reticulum, J. Biol. Chem., 271, 30736–30740
Tietze, C., Schlesinger, P., and Stahl, P. (1982) Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling, J. Cell. Biol., 92, 417–424
Wileman, T., Boshans, R. L., Schlesinger, P., and Stahl, P. (1984) Monesin inhibits recycling of macrophage mannose-glycoprotein receptors and ligand delivery to lysosomes, Biochem. J., 220, 665–675
Montaner, L. J., da Silva, R. P., Sun, J., et al. (1999) Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10, J. Immunol., 162, 4606–4613
Crouch, E. C. (1998) Collectins and pulmonary host defense, Am. J. Respir. Cell. Mol. Biol., 19, 177–201
Wright, J. R. (1997) Immunomodulatory functions of surfactant, Physiol. Rev., 77, 931–962
Haagsman, H. P. (1998) Interactions of surfactant protein A with pathogens, Biochim. Biophys. Acta, 1408, 264–277
Holmskov, U. L. (2000) Collectins and collectin receptors in innate immunity, APMIS Suppl., 100, 1–59
Lawson, P. R. and Reid, K. B. (2000) The roles of surfactant proteins A and D in innate immunity, Immunol. Rev., 173, 66–78
Hakansson, K. and Reid, K. B. (2000) Collectin structure: a review, Protein Sci., 9, 1607–1617
Ohtani, K., Suzuki, Y., Eda, S., et al. (1999) Molecular cloning of a novel human collectin from liver (CL-L1), J. Biol. Chem., 274, 13681–13689
Khoor, A., Gray, M. E., Hull, W. M., Whisett, J. A., and Stahlman, M. T. (1993) Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn, J. Histochem. Cytochem., 41, 1311–1119
Khubchandani, K. R. and Snyder, J. M. (2001) Surfactant protein A (SP-A): the alveolus and beyond, FASEB J., 15, 59–69
Madsen, J., Kliem, A., Tornoe, I., et al. (2000) Localization of lung surfactant protein D (SP-D) on mucosal surfaces in human tissues, J. Immunol., 164, 5866–5870
Hakansson, K., Lim, N. K., Hoppe, H. J., and Reid, K. B. (1999) Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D, Structure Fold. Des., 7, 255–264
Crouch, E. C. and Whitsett, J. A. (2003) Diverse roles of lung collectins in pulmonary innate immunity. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A. (eds.), Humana Press, Totowa, NJ, pp. 205–229
Voss, T., Melchers, K., Scheirle, G., and Schafer, K. P. (1991) Structural comparison of recombinant pulmonary composition of natural protein SP-A derived from two human coding sequences: implication for the chain composition of natural human SP-A, Am. J. Respir. Cell. Mol. Biol., 4, 88–94
Karinch, A. M., Deiter, G., Ballard, P. L., and Floros, J. (1998) Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture, Biochim. Biophys. Acta, 1398, 192–202
McCormick, S. M. and Mendelson, C. R. (1994) Human SP-A1 and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids, Am. J. Physiol., 266, L367–L374
Van Eijk, M., Haagsman, H. P., Skinner, T., et al. (2000) Porcine lung surfactant protein D: complementary DNA cloning, chromosomal localization, and tissue distribution, J. Immunol., 164, 1442–1450
Crouch, E. and Wright, J. R. (2001) Surfactant proteins A and D and pulmonary host defense, Annu. Rev. Physiol., 63, 521–554
Madan, T., Kishore, U., Shah, A., et al. (1997) Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils, Clin. Exp. Immunol, 110, 241–249
Allen, M. J., Harbeck, R., Smith, B., Voelker, D. R., and Mason, R. J. (1999) Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia, Infect. Immun., 67, 4563–4569
Madan, T., Kishore, U., Singh, M., et al. (2001) Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis, Infect. Immun., 69, 2728–2731
Williams, M. D., Wright, J. R., March, K. L., and Martin, W. J. (1996) Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages, Am. J. Respir. Cell. Mol. Biol., 14, 232–238
Zimmerman, P. E., Voelker, D. R., McCormack, F. X., Paulsrud, J. R., and Martin, W. J. (1992) 120-kD surface glucoprotein of Pneumocystis carinii is a ligand for surfactant protein A, J. Clin. Invest., 89, 143–149
O’Riordan, D. M., Standing, J. E., Kwon, K. Y., et al. (1995) Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages, J. Clin. Invest., 95, 2699–2710
McCormack, F. X., Festa, A. L., Andrews, R. P., Linke, M., and Walzer, P. D. (1997) The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii, Biochemistry, 36, 8092–8099
Vuk-Pavlovic, Z., Diaz-Montes, T., Standing, J. E., and Limper, A. H. (1998) Surfactant protein D binds to cell wall β-glucans, Am. J. Respir. Cell. Mol. Biol., 157, A236
Limper, A. H., Crouch, E. C., O’Riordan, D. M., et al. (1995) Surfactant protein D modulates interaction of Pneumocystis carinii with alveolar macrophages, J. Lab. Clin. Med., 126, 416–422
Kuan, S. F., Rust, K., and Crouch, E. (1992) Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage, J. Clin. Invest., 90, 97–106
Kalina, M., Blau, H., Riklis, S., and Kravtsov, V. (1995) Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions, Am. J. Physiol., 268, L144–L151
Van Iwaarden, J. F., Pikaar, J. C., Storm, J., et al. (1994) Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides, Biochem. J., 303, 407–411
Borron, P., McIntosh, J. C., Korfhagen, T. R., et al. (2000) Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo, Am. J. Physiol. (Lung Cell Mol. Physiol.), 278, L840–L847
Greene, K. E., Whitsett, J. A., Korfhagen, T. R., and Fisher, J. H. (2000) SP-D expression regulates endotoxin mediated lung inflammation in vivo, Am. J. Respir. Crit. Care, 161, A515
Bridges, J. P., Davis, H. W., Damodarasamy, M., et al. (2000) Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury, J. Biol. Chem., 275, 38848–38855
Stehle, T. and Larvie, M. (2003) Structures of complement control proteins. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 231–253
Janaway, C. A., Jr., Travers, P., Walport, M., and Shlomchik, M. J. (eds.) (2001) Immunobiology: The Immune System in Health and Disease, 5th ed., Garland Publishing, New York
Baron, S. (ed.) (1996) Medical Microbiology, 4th ed., The University of Texas Branch at Galveston, Galveston, TX
Hourcade, D., Holers, V. M., and Atkinson, J. P. (1989) The regulators of complement activation (RCA) gene cluster, Adv. Immunol., 45, 381–416
Liszewski, M. K., Post, T. W., and Atkinson, J. P. (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster, Annu. Rev. Biochem., 9, 431–455
Hourcade, D., Liszewski, M. K., Krych-Goldberg, M., and Atkinson, J. P. (2000) Functional domains, structural variation and pathogen interactions of MCP, DAF and CRI, Immunopharmacology, 49, 103–116
Pangburn, M. K. (2000) Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement, Immunopharmacology, 49, 149–157
Kirkitadze, M. D. and Barlow, P. N. (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation, Immunol. Rev., 180, 146–157
Kirschfink, M. (2001) Targeting complement in therapy, Immunol. Rev., 180, 177–189
Dörig, R. E., Marcil, A., Chopra, A., and Richardson, C. D. (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain), Cell, 75, 295–305
Naniche, D., Varior-Krishnan, G., Cervoni, F., et al. (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus, J. Virol., 67, 6025–6032
Okada, N., Liszewski, M. K., Atkinson, J. P., and Caparon, M. (1995) Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A Streptococcus, Proc. Natl. Acad. Sci. U.S.A., 92, 2489–2493
Kallstrom, H., Liszewski, M. K., Atkinson, J. P., and Jonsson, A. B. (1997) Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria, Mol. Microbiol., 25, 639–647
Santoro, F., Kennedy, P. E., Locatelli, G., et al. (1999) CD46 is a cellular receptor for human herpesvirus 6, Cell, 99, 817–827
Karnauchow, T. M., Dawe, S., Lublin, D. M., and Dimock, K. (1998) Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding, J. Virol., 72, 9380–9383.\enlargethispage{12pt}
Bergelson, J. M., Chan, M., Solomon, K. R., et al. (1994) Decay-accelerating factor (CD55), a glycosylphosphatidyl-inositol-anchored complement regulatory protein, is a receptor for several echoviruses, Proc. Natl. Acad. Sci. U.S.A., 91, 6245–6249
Ward, T., Pipkin, P. A., Clarkson, N. A., et al. (1994) Decay-accelerating factor CD55 is identified as a receptor for echovirus-7 using CELICS, a rapid immuno-focal cloning method, EMBO J., 13, 5070–5074
Clarkson, N. A., Kaufman, R., Lublin, D. M., et al. (1995) Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding, J. Virol., 69, 5497–5501
Bergelson, J. M., Modlin, J. F., Wieland-Alter, W., et al. (1997) Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell-surface receptors, J. Infect. Dis., 175, 697–700
Bergelson, J. M., Cunningham, J. A., Droguett, G., et al. (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5, Science, 275, 1320–1323
Fingeroth, J. D., Weis, J. J., Tedder, T. F., et al. (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2, Proc. Natl. Acad. Sci. U.S.A., 81, 4510–4514
Weis, J. J., Tedder, T. F., and Fearon, D. T. (1984) Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes, Proc. Natl. Acad. Sci. U.S.A., 81, 884–885
Nemerow, G. R., Wolfert, R., McNaughton, M. E., and Cooper, N. R. (1985) Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2), J. Virol., 55, 347–351
Sharma, A. K. and Pangburn, M. K. (1997) Localization by site-directed mutagenesis of the site in human complement factor H that binds to Streptomyces pyogenes M protein, Infect. Immun., 65, 484–487
Thern, A., Stenberg, L., Dahlback, B., and Lindahl, G. (1995) Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system, J. Immunol., 154, 375–386
Hellwage, J., Meri, T., Heikkila, T., et al. (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi, J. Biol. Chem., 276, 8427–8435
Norman, D. G., Barlow, P. N., Baron, M., et al. (1991) Three-dimensional structure of a complement control protein module in solution, J. Mol. Biol., 219, 717–725
Barlow, P. N., Baron, M., Norman, D. G., et al. (1991) Secondary structure of a complement control protein module by two-dimensional 1H NMR, Biochemistry, 30, 997–1004
Barlow, P. N., Norman, D. G., Steinkasserer, A., et al. (1992) Solution structure of the fifth repeat of factor H: a second example of the complement control protein module, Biochemistry, 31, 3626–3634
Barlow, P. N., Steinkasserer, A., Norman, D. G., et al. (1993) Solution structure of a pair of complement modules by nuclear magnetic resonance, J. Mol. Biol., 232, 268–284
Wiles, A. P., Shaw, G., Bright, J., et al. (1997) NMR studies of a viral protein that mimicks the regulators of complement activation, J. Mol. Biol., 272, 253–265
Henderson, C. E., Bromek, K., Mullin, N., et al. (2001) Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein, J. Mol. Biol., 307, 323–339
Casasnovas, J. M., Larvie, M., and Stehle, T. (1999) Crystal structure of two CD46 domains reveals an extended measles virus-binding surface, EMBO J., 18, 2911–2922
Szakonyi, G., Guthridge, J. M., Li, D., et al. (2001) Structure of complement receptor 2 in complex with its C3d ligand, Science, 292, 1725–1728
Murthy, K. H. M., Smith, S. A., Ganesh, V. K., et al. (2001) Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparin sulfate proteoglycans, Cell, 104, 301–311
Schwarzenbacher, R., Zeth, K., Diederichs, K., et al. (1999) Structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome, EMBO J., 18, 6228–6239
Bouma, B., de Groot, P. G., van den Elsen, J. M., et al. (1999) Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure, EMBO J., 18, 5166–5174
Gaboriaud, C. G., Rossi, V., Bally, I., Arlaud, G. J., and Fontecilla-Camps, J. C. (2000) Crystal structure of the catalytic domain of human complement C1s: a serine protease with a handle, EMBO J., 19, 1755–1765
Gadjeva, M., Verschoor, A., and Carroll, M. C. (2003) The role of complement in innate and adaptive immunity. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 305–319
Law, S. K. and Dodds, A. W. (1997) The internal thioester and the covalent binding properties of the complement proteins C3 and C4, Protein Sci., 6, 263–274
Law, S. K., Lichtenberg, N. A., and Levine, R. P. (1980) Covalent binding and hemolytic activity of complement proteins, Proc. Natl. Acad. Sci. U.S.A., 77, 7194–7198
Cooper, N. R. (1985) The classical complement pathway: activation and regulation of the first complement component, Adv. Immunol., 37, 151–216
Boes, M. (2000) Role of natural and immune IgM antibodies in immune responses, Mol. Immunol., 37, 1141–1149
Heyman, B. (2000) Regulation of antibody responses via antibodies, complement, and Fc receptors, Annu. Rev. Immunol., 18, 709–737
Fearon, D. T. (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte, J. Exp. Med., 152, 20–30
Carroll, M. C., Alicot, E. M., Katzman, P. J., et al. (1988) Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4- binding protein in the RCA locus on human chromosome 1, J. Exp. Med., 167, 1271–1280
Tas, S. W., Klickstein, L. B., Barbashov, S. F., and Nicholson-Weller, A. (1999) C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion, J. Immunol., 163, 5056–5063
Klickstein, L. B., Barbashov, S. F., Liu, T., Jack, R. M., and Nicholson-Weller, A. (1997) Complement receptor type 1 (CR1, CD35) is a receptor for C1q, Immunity, 7, 345–355
Ghiran, I., Barbashov, S. F., Klickstein, L. B., et al. (2000) Complement receptor 1/CD35 is a receptor for mannan-binding lectin, J. Exp. Med., 192, 1797–1808
Law, S. K. (1988) C3 receptors on macrophages, J. Cell Sci. Suppl., 9, 67–97
Gutsmann, T., Müller, M., Carroll, S. F., MacKenzie, R. C., Wiese, A., and Seydel, U. (2001) Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells, Infect. Immun., 69(11), 6942–6950
Agellon, L. B., Quinet, E. M., Gillette, T. G., Drayna, D. T., Brown, M. L., and Tall, A. R. (1990) Organization of the human cholesteryl ester transfer protein gene, Biochemistry, 29, 1372–1376
Kirschning, C. J., Au-Young , J., Lamping, N., Reuter, D., Pfeil, D., Seilhamer, J. J., and Schumann, R. R. (1997) Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins, Genomics, 46, 416–425
Tobias, P. S., Mathison, J. C., and Ulevitch, R. J. (1988) A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis, J. Biol. Chem., 263, 13479–13481
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., and Ulevitch R J. (1990) Structure and function of lipopolysaccharide binding protein, Science, 249, 1429–1431
Ramadori, G., Meyer zum Buschenfelde, K. H., Tobias, P. S., Mathison, J. C., and Ulevitch R. J. (1990) Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes, Pathobiology, 58, 89–94
Vreugdenhil, A. C., Dentener, M. A., Snoek, A. M., Greve, J. W., and Buurman, W. A. (1999) Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response, J. Immunol., 163, 2792–2798
Tobias, P. S., Mathison, J., Mintz, D., Lee, J. D., Kravchenko, V., Kato, K., Pugin, J., and Ulevitch, R. J. (1992) Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation, Am. J. Respir. Cell Mol. Biol., 7, 239–245
Kirschning, C., Unbehaun, A., Lamping, N., Pfeil, D., Herrmann, F., and Schumann, R. R. (1997) Control of transcriptional activation of the lipopolysaccharide binding protein (LBP) gene by proinflammatory cytokines, Cytokines Cell. Mol. Ther., 3, 59–62 [Erratum: Cytokines Cell. Mol. Ther., 3:137 (1998)]
Lamping, N., Dettmer, R., Schroeder, N. W. J., Pfeil, D., Hallatschek, W., Burger, R., and Schumann, R. R. (1998) LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria, J. Clin. Invest., 101, 2065–2071
Tobias, P. S., Soldau, K., and Ulevitch, R. J. (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum, J. Exp. Med., 164, 777–793
Tobias, P. S., Soldau, K., and Ulevitch, R. J. (1989) Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein, J. Biol. Chem., 264, 10867–10871
Morrison, D. C. and Ryan, J. L. (1987) Endotoxins and disease mechanisms, Annu. Rev. Med., 38, 417–432
Rietschel, E. T., Brade, H., Brade, L., Brandenburg, K., Schade, U., Seydel, U., Zahringer, U., Galanos, C., Luderitz, O., and Westphal, O. (1987) Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity, Prog. Clin. Biol. Res., 231, 25–53
Kielian, T. L. and Blecha, F. (1995) CD14 and other recognition molecules for lipopolysaccharide: a review, Immunopharmacology, 29(3), 187–205
Bone, R. C. (1991) The pathogenesis of sepsis, Ann. Intern. Med., 115, 457–469
Glauser, M. P., Zanetti, G., Baumgartner, J. D., and Cohen, J. (1991) Septic shock: pathogenesis, Lancet, 338, 732–736
Ulevitch, R. J. and Tobias, P. S. (1999) Recognition of gram-negative bacteria and endotoxin by the innate immune system, Curr. Opin. Immunol., 11, 19–22
Blunck, R., Scheel, O., Müller, M., Brandenburg, K., Seitzer, U., and Seydel, U. (2001) New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling, J. Immunol., 166, 1009–1015
Maruyama, N., Yasunori, K., Yamauchi, K., Aizawa, T., Ohrui, T., Nara, M., Oshiro, T., Ohno, L., Tanura, G., Shimura, S., Saschi, H., Tahishima, T., and Shirato, K. (1994) Quinine inhibits production of tumor necrosis factor-α from human alveolar macrophages, Am. J. Respir. Cell. Mol. Biol., 10, 514–520
Todd, R. F., Bhan, A. K., Kabawat, S. E., and Schlossman, S. F. (1984) Human myelomonocytic differentiation antigens defined by monoclonal antibodies. In: Leucocyte Typing, Human Leucocyte Differentiation Antigens Detected by Monoclonal Antibodies (Bernard, A., Boumsell, L., Dausset, J., Milstein, C., and Schlossman, S. F., eds.), Springer-Verlag, Oxford, pp. 424–433
Griffin, J. D. and Schlossman, S. F. (1984) Expression of myeloid differentiation antigens in acute myeloblastic leukemia. In: Leucocyte Typing, Human Leucocyte Differentiation Antigens Detected by Monoclonal Antibodies (Bernard, A., Boumsell, L., Dausset, J., Milstein, C., and Schlossman, S. F., eds.), Springer-Verlag, Oxford, pp. 404–410
Hogg, N. and Horton, M. A. (1986) Myeloid antigens: new and previously defined clusters. In: Leucocyte Typing III, White Cell Differentiation Antigens (McMichael, A. J., ed.), Oxford University Press, New York, pp. 576–602
Labeta, M. O., Landmann, R., Obrecht, J. P., and Obrist, R. (1991) Human B cells express membrane-bound and soluble forms of the CD 14 myeloid antigen, Mol. Immunol., 28, 115–122
Morabito, F., Prasthofer, E. F., Dunlap, N. E., Grossi, C. E., and Tilden, A. B. (1987) Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1, Blood, 70, 1750–1757
Zeigler-Heitbrock, H. W. L., Pechumer, H., Petersmann, I., Durieux, J. J., Vita, N., Labeta, M. O., and Strobel, M. (1994) CD14 is expressed and functional in human B cells, Eur. J. Immunol., 24, 1937–1940
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, 1431–1433
Tobias, P. S. (2003) Lipopolysaccharide-binding protein and CD14. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 255–265
Pugin, J., Schurer-Maly, C.-C., Leturcq, D., et al. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14, Proc. Natl. Acad. Sci. U.S.A., 90, 2744–2748
Simmons, D. L., Tan, S., Tenen, D. G., Nicholson Weller, A., and Seed, B. (1989) Monocyte antigen CD14 is a phospholipid anchored membrane protein, Blood, 73, 284–289
Haziot, A., Ferrero, E., Xing, Y. L., Stewart, C. L., and Goyert, M. (1994) CD14- deficient mice are exquisitely insensitive to the effects of LPS. In: Bacterial Endotoxins (Levin, J., Alving, C. R., Munford, R. S., and Redl, H., eds.), Wiley-Liss, New York, pp. 349–351
Moore, K. J., Andersson, L. P., Ingalls, R. R., et al. (2000) Divergent response to LPS and bacteria in CD14-deficient murine macrophages, J. Immunol., 165, 4272–4280
Haziot, A., Lin, X. Y., Zhang, F., and Goyert, S. M. (1998) The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14- independent, J. Immunol., 160, 2570–2572
Le Van, T. D., Bloom, J. W., Bailey, T. J., et al. (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity, J. Immunol., 167, 5838–5844
Zhang, D. E., Hetherington, C. J., Tan, S., et al. (1994) Sp1 is a critical factor for the monocytic specific expression of human CD14, J. Biol. Chem., 269, 11425–11434
Vercelli, D., Baldini, M., Stern, D., et al. (2001) CD14: a bridge between innate immunity and adaptive IgE responses, J. Endotoxin Res., 7, 45–48
Williams, H., Robertson, C., Stewart, A., et al. (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood, J. Allergy Clin. Immunol., 103, 125–138
Strachan, D., Sibbald, B., Weiland, S., et al. (1997) Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the Internaltional Study of Asthma and Allergies in Childhood (ISAAC), Pediatr. Allergy Immunol., 8, 161–176
Arias, M. A., Rey Nores, J. E., Vita, N., et al. (2000) Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production, J. Immunol., 164, 3480–3486
Shimada, K., Watanabe, Y., Mokuno, H., et al. (2000) Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men, Am. J. Cardiol., 86, 682–684
Unkelbach, K., Gardemann, A., Kostrzewa, M., et al. (1999) A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile, Arterioscler. Thromb. Vasc. Biol., 19, 932–938
Hubacek, J. A., Rothe, G., Pit’ha, J., et al. (1999) C(–260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction, Circulation, 99, 3218–3220
Ito, D., Murata, M., Tanahashi, N., et al. (2000) Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease, Stroke, 31, 2661–2664
Moser, B. and Loetscher, P. (2001) Lymphocyte traffic control by chemokines, Nat. Immunol., 2, 123–128
Thelen, M. (2001) Dancing to the tune of chemokines, Nat. Immunol., 2, 129–134
Yoshie, O. (2000) Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system, Springer Semin. Immunopathol., 22, 371–391
Gerard, C. and Rollins, B. J. (2001) Chemokines and disease, Nat. Immunol., 2, 108–115
Matsukawa, A., Hogaboam, C. M., Lukacs, N. W., and Kunkel, S. L. (2000) Chemokines and innate immunity, Rev. Immunogenet., 2, 339–358
Kunkel, S. L. (1999) Through the looking glass: the diverse in vivo activities of chemokines, J. Clin. Invest., 104, 1333–1334
Rossi, D. and Zlotnik, A. (2000) The biology of chemokines and their receptors, Annu. Rev. Immunol., 18, 217–242
Scapini, P., Lapinet-Vera, J. A., Gasperini, S., et al. (2000) The neutrophil as a cellular source of chemokines, Immunol. Rev., 177, 195–203
Clark, G. J., Angel, N., Kato, M., et al. (2000) The role of dendritic cells in the innate immune system, Microbes Infect., 2, 257–272
Stockwin, L. H., McGonagle, D., Martin, I. G., and Blair, G. E. (2000) Dendritic cells: immunological sentinels with a central role in health and disease, Immunol. Cell Biol., 78, 91–102
Caux, C., Ait-Yahia, S., Chemin, K., et al. (2000) Dendritic cell biology and regulation of dendritic cell trafficking by chemokines, Springer Semin. Immunopathol., 22, 345–369
Gunn, M. D., Kyuwa, S., Tam, C., et al. (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization, J. Exp. Med., 189, 451–460
Chan, V. W., Kothakota, S., Rohan, M. C., et al. (1999) Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells, Blood, 93, 3610–3616
Willimann, K., Legler, D. F., Loetscher, M., et al. (1998) The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7, Eur. J. Immunol., 28, 2025–2034
Demangel, C. and Britton, W. J. (2000) Interaction of dendritic cells with mycobacteria: where the action starts, Immunol. Cell Biol., 78, 318–324
McWilliam, A. S., Napoli, S., Marsh, A. M., et al. (1996) Dendritic cells are recruited into airway epithelium during the inflammatory response to a broad spectrum of stimuli, J. Exp. Med., 184, 2429–2432
Rescigno, M., Granucci, F., and Ricciardi-Castagnoli, P. (2000) Molecular events of bacterial-induced maturation of dendritic cells, J. Clin. Immunol., 20, 161–166
Burdin, N. and Kronenberg, M. (1999) CD1mediated immune responses to glycolipids, Curr. Opin. Immunol., 11, 326–331
Porcelli, S.A. and Modlin, R. L. (1999) The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids, Annu. Rev. Immunol., 17, 297–329
Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., Taniguchi, M., and Nishimura, T. (1999) The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells, J. Exp. Med., 189, 1121–1128
Yokoyama, W. M. (2003) The role of natural killer cells in innate immunity to infection. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 321–339
Yokoyama, W. M., Kim, S., and French, A. R. (2004) The dynamic life of natural killer cells, Annu. Rev. Immunol., 22, 405–429
Trinchieri, G. (1989) Biology of natural killer cells, Adv. Immunol., 47, 187–376
Yokoyama, W. M. (1999) Natural killer cells. In: Fundamental Immunology (Paul, W. E., ed.), Lippincott-Raven, New York, pp. 575–603
Anderson, P., Caligiuri, M., Ritz, J., and Schlossman, S. F. (1989) CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex, Nature, 341, 159–162
Lanier, L. L., Yu, G., and Phillips, J. H. (1989) C-association of CD3 zeta with receptor (CD16) for IgG on human natural killer cells, Nature, 342, 803–805
Lanier, L. L., Phillips, J. H., Hackett, J., Jr., Tutt, M., and Kumar, V. (1986) Natural killer cells: definition of a cell type rather than a function, J. Immunol., 137, 2735–2739
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., and Salazar-Mather, T. P. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines, Annu. Rev. Immunol., 17, 189–220
Biron, C. A., Byron, K. S., and Sullivan, J. L. (1989) Severe herpesvirus infections in an adolescent without natural killer cells, N. Engl. J. Med., 320, 1731–1735
Jawahar, S., Moody, C., Chan, M., et al. (1996) Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II), Clin. Exp. Immunol., 103, 408–413
Robertson, M. J., Williams, B. T., Christopherson, K., Brahmi, Z., and Hromas, R. (2000) Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines, Cell. Immunol., 199, 8–14
Rook, A. H., Masur, H., Lane, H. C., et al. (1983) Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome, J. Clin. Invest., 72, 398–403
Bonavida, B., Katz, J., and Gottlieb, M. (1986) Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS- related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL-2, J. Immunol., 137, 1157–1163
Lusso, P., Malnati, M. S., Garzino-Demo, A., et al. (1993) Infection of natural killer cells by human herpesvirus 6, Nature, 362, 458–462
Tripp, C. S., Wolf, S. F., and Unanue, E. R. (1993) Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist, Proc. Natl. Acad. Sci. U.S.A., 90, 3725–3729
Tripp, C. S., Gately, M. K., Hakimi, J., Ling, P., and Unanue, E. R. (1994) Neutralization of IL-12 decreases resistance to Listeria in SCID and S.B-17 mice, reversal by IFN-gamma, J. Immunol., 152, 1883–1887
Guidotti, L. G. and Chisari, F. V. (2001) Noncytolytic control of viral infections by the innate and adaptive immune response, Annu. Rev. Immunol., 19, 65–91
Waldmann, T. A. and Tagaya, Y. (1999) The multifaceted regulation of interleukin- 15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens, Annu. Rev. Immunol., 17, 19–49
Kennedy, M. K., Glaccum, M., Brown, S. N., et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, J. Exp. Med., 191, 771–780
Lodolce, J. P., Boone, D. L., Chai, S., et al. (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation, Immunity, 9, 669–676
Gosselin, J., Tomoiu, A., Gallo, R. C., and Flamand, L. (1999) Interleukin-15 as an activator of natural killer cell-mediated antiviral response, Blood, 94, 4210–4219
Fawaz, L. M., Sharif-Askari, E., and Menezes, J. (1999) Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study, J. Immunol., 163, 4473–4480
Ahmad, A., Sharif-Askari, E., Fawaz, L., and Menezes, J. (2000) Innate immunity response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction, J. Virol., 74, 7196–7203
Tsunobuchi, H., Nishimura, H., Goshima, F., et al. (2000) A protective role of interleukine-15 in a mouse model for systemic infection with herpes simplex virus, Virology, 275, 57–66
Henkart, P. A. (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules, Immunity, 1, 343–346
Motyka, B., Korbutt, G., Pinkoski, M. J., et al. (2000) Mannose 6- phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis, Cell, 103, 491–500
Zamai, L., Ahmad, M., Bennett, I. M., et al. (1998) Natural killer (NK) cell- mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells, J. Exp. Med., 188, 2375–2380
Bradley, M., Zeytun, A., Rafi-Janajreh, A., Nagarkatti, P. S., and Nagarkatti, M. (1998) Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells, Blood, 92, 4248–4255
Kärre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, Nature, 319, 675–678
Ljunggren, H. G. and Kärre, K. (1990) In search of the “missing self”: MHC molecules and NK cell recognition, Immunol. Today, 11, 237–244
Kärre, K. (1985) Role of target histocompatibility antigens in regulation of natural killer activity: a reevaluation and a hypothesis. In: Mechanisms of Cytotoxicity by NK Cells (Herberman, R. B. and Callewaert, D. M., eds.), Academic Press, Orlando, FL, pp. 81–92
Karlhofer, F. M., Ribaudo, R. K., and Yokoyama, W. M. (1992) MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells, Nature, 358, 66–70
Yokoyama, W. M. (1997) What goes up must come down: the emerging spectrum of inhibitory receptors, J. Exp. Med., 186, 1803–1808
Long, E. O. (1999) Regulation of immune responses through inhibitory receptors, Annu. Rev. Immunol., 17, 875–904
Correa, I. and Raulet, D. H. (1995) Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells, Immunity, 2, 61–71
Orihuela, M., Margulies, D. H., and Yokoyama, W. M. (1996) The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand, Proc. Natl. Acad. Sci. U.S.A., 93, 11792–11797
Michaelsson, J., Achour, A., Salcedo, M., et al. (2000) Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers, Eur. J. Immunol., 30, 300–307
Mandelboim, O., Wilson, S. B., Vales-Gomez, M., Reyburn, H. T., and Strominger, J. L. (1997) Self and viral peptides can initiate lysis by autologous natural killer cells, Proc. Natl. Acad. Sci. U.S.A., 94, 4604–4609
Yokoyama, W. M. (1995) Natural killer cell receptors, Curr. Opin. Immunol., 7, 110–120
Biassoni, R., Cantoni, C., Falco, M., et al. (1996) The human leucocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions, J. Exp. Med., 183, 645–650
Idriss, A. H., Smith, H. R. C., Mason, L. H., et al. (1999) The natural killer cell complex genetic locus, Chok, encodes Ly49D, a target recognition receptor that activates natural killing, Proc. Natl. Acad. Sci. U.S.A., 96, 6330–6335
Nakamura, M. C., Linnemeyer, P. A., Niemi, E. C., et al. (1999) Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity, J. Exp. Med., 189, 493–500
George, T. C., Mason, L. H., Ortaldo, J. R., Kumar, V., and Bennett, M. (1999) Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells, J. Immunol., 162, 2035–2043
Karlhofer, F. M., Ribaudo, R. K., and Yokoyama, W. M. (1992) The interaction of Ly-49 with H-2Dd globally inactivates natural killer cell cytolytic activity, Trans. Assoc. Am. Physicians, 105, 72–85
Correa, I., Corral, L., and Raulet, D. H. (1994) Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells, Eur. J. Immunol., 24, 1323–1331
Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R., and Cresswell, P. (1989) Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes, Proc. Natl. Acad. Sci. U.S.A., 86, 2361–2364
Cohen, G. B., Gandhi, R. T., Davis, D. M., et al. (1999) The selective downregulation of class I major histopatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells, Immunity, 10, 661–671
Reyburn, H. T., Mandelboim, O., Vales-Gomez, M., et al. (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells, Nature, 386, 514–517
Farrell, H. E., Vally, H., Lynch, D. M., et al. (1997) Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo, Nature, 386, 510–514
Cosman, D., Fanger, N., Borges, L., et al. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules, Immunity, 7, 273–282
Tomasec, P., Braud, V. M., Rickards, C., et al. (2000) Surface expression of HLA- E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40, Science, 287, 1031
Ulbrecht, M., Martinozzi, S., Grzeschik, M., et al. (2000) Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis, J. Immunol., 164, 5019–5022
Ishido, S., Choi, J. K., Lee, B. S., et al. (2000) Inhibition of natural killer cell- mediated cytotoxicity by Kaposi’s sarcoma-associated herpesvirus K5 protein, Immunity, 13, 365–374
Schmidt, R. E., Bartley, G., Levine, H., Schlossman, S. F., and Ritz, J. (1985) Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells, J. Immunol., 135, 1020–1025
Scalzo, A. A., Fitzgerald, N. A., Simmons, A., La Vista, A. B., and Shellam, G. R. (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen, J. Exp. Med., 171, 1469–1483
Delano, M. L. and Brownstein, D. G. (1995) Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype, J. Virol., 69, 5875–5877
Pereira, R. A., Scalzo, A., and Simmons, A. (2001) Cutting edge: a NK complex- linked locus governs acute versus latent herpes simplex virus infection of neurons, J. Immunol., 166, 5869–5873
Bromley, S. K., Burack, W. R., Johnson, K. G., et al. (2001) The immunological synapse, Annu. Rev. Immunol., 19, 375–396
Matsukawa, A., Lukacs, N. W., Standiford, T. J., Chensue, S. W., and Kunkel, S. L. (2000) Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo, J. Immunol., 164, 1699–1704
Odum, N., Bregenholt, S., Eriksen, K. W., et al. (1999) The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells, Tissue Antigens, 54, 572–577
D’Ambrosio, D., Iellem, A., Bonecchi, R., et al. (1998) Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells, J. Immunol., 161, 5111–5115
Zingoni, A., Soto, H., Hedrick, J. A., et al. (1998) The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells, J. Immunol., 161, 547–551
Campbell, J. D. and HayGlass, K. T. (2000) T cell chemokine receptor expression in human Th1- and Th2-associated diseases, Arch. Immunol. Ther. Exp. (Warsz.), 48, 451–456
Naumann, M. (2000) Nuclear factor-kappa B activation and innate immune response in microbial pathogen infection, Biochem. Pharmacol., 60, 1109–1114
Lillard, J. W., Boyaka, P. N., Taub, D. D., and McGhee, J. R. (2001) RANTES potentiates antigen-specific mucosal immune responses, J. Immunol., 166, 162–169
Hogaboam, C. M., Smith, R. E., and Kunkel, S. L. (1998) Dynamic interactions between lung fibroblasts and leukocytes: implications for fibrotic lung disease, Proc. Assoc. Am. Physicians, 110, 313–320
Smith, R. S., Smith, T. J., Blieden, T. M., and Phipps, R. P. (1997) Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation, Am. J. Pathol., 151, 317–322
Xia, Y., Pauza, M. E., Feng, L., and Lo, D. (1997) ReIB regulation of chemokine expression modulates local inflammation, Am. J. Pathol., 151, 375–387
Murphy, P. M. (2001) Viral exploitation and subversion of the immune system through chemokine mimicry, Nat. Immunol., 2, 116–122
Scarlatti, G., Tresoldi, E., Bjorndal, A., et al. (1997) In vivo evolution of HIV-1 co- receptor usage and sensitivity to chemokine-mediated suppression, Nat. Med., 3, 1259–1265
Simmons, G., Reeves, J. D., Hibbits, S., et al. (2000) Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands, Immunol. Rev., 177, 112–126
Howie, S., Ramage, R., and Hewson, T. (2000) Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design, Am. J. Respir. Crit. Care Med., 162, S141–S145
Holland, S. M. (1996) Host defense against nontuberculous mycobacterial infections, Semin. Respir. Infect., 11, 217–230
Endres, M. J., Garlisi, C. G., Xiao, H., Shan, L., and Hedrick, J. A. (1999) The Kaposi’s sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8, J. Exp. Med., 189, 1993–1998
Sozzani, S., Luini, W., Bianchi, G., et al. (1998) The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant, Blood, 92, 4036–4039
Kledal, T. N., Rosenkilde, M. M., Coulin, F., et al. (1997) A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus, Science, 277, 1656–1659
Chen, S., Bacon, K. B., Li, L., et al. (1998) In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II, J. Exp. Med., 188, 193–198
Penfold, M. E., Dairaghi, D. J., Duke, G. M. (1999) Cytomegalovirus encodes a potent alpha chemokine, Proc. Natl. Acad. Sci. U.S.A., 96, 9839–9844
Zhang, P., Summer, W. R., Bagby, G. J., and Nelson, S. (2000) Innate immunity and pulmonary host defense, Immunol. Rev., 173, 39–51
Itakura, M., Tokuda, A., Kimura, H., et al. (2001) Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation, J. Immunol., 166, 2071–2079
Standiford, T. J. (1997) Cytokines and pulmonary host defenses, Curr. Opin. Pulm. Med., 3, 81–88
Standiford, T. J. and Huffnagle, G. B. (1997) Cytokines in host defense against pneumonia, J. Invest. Med., 45, 335–345
Brun-Bruisson, C. (2000) The epidemiology of the systemic inflammatory response, Intensive Care Med., 26, S64–S74
Fry, D. E. (2000) Sepsis syndrome, Am. Surg., 66, 126–132
Glauser, M. P. (2000) Pathophysiologic basis of sepsis: considerations for future strategies of intervention, Crit. Care Med., 28, S4–S8
Deitch, E. A. and Goodman, E. R. (1999) Prevention of multiple organ failure, Surg. Clin. North Am., 79, 1471–1488
Matsukawa, A., Hogaboam, C. M., Lukacs, N. W., et al. (1999) Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-link between MCP-1 and leukotrine B4, J. Immunol., 163, 6148–6154
Matsukawa, A., Hogaboam, C. M., Lukacs, N. W., et al. (2000) Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis, Exp. Mol. Pathol., 68, 77–84
Zisman, D. A., Kunkel, S. L., Strieter, R. M., et al. (1997) MCP-1 protects mice in lethal endotoxemia, J. Clin. Invest., 99, 2832–2836
Matsukawa, A., Hogaboam, C. M., Lukacs, N. W., et al. (2000) Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response, J. Immunol., 164, 5362–5368
Steinhauser, M. L., Hogaboam, C. M., Matsukawa, A., et al. (2000) Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis, Infect. Immun., 68, 6108–6114
Ganz, T. and Lehrer, R. I. (2003) Antimicrobial peptides. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 287–303
Sablon, E., Contreras, B., and Vandamme, E. (2000) Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis, Adv. Biochem. Eng. Biotechnol., 68, 21–60
Haseltine, C., Hill, T., Montalvo-Rodriguez, R., et al. (2001) Secreted euryarchaeal microhalocins kill hyperthermophillic crenarchaea, J. Bacteriol., 183, 287–291
Hancock, R. E. and Bell, A. (1988) Antibiotic uptake into gram-negative bacteria, Eur. J. Clin. Microbiol. Infect. Dis., 7, 713–720
Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic membranes, Biochim. Biophys. Acta, 1462, 55–70
Ludtke, S. J., He, K., Heller, W. T., et al. (1996) Membrane pores induced by magainin, Biochemistry, 35, 13723–13728
Higashimoto, Y., Kodama, H., Jelokhani-Niaraki, M., Kato, F., and Kondo, M. (1999) Structure-function relationship of model Aib-containing peptides as ion transfer intermembrane templates, J. Biochem. (Tokyo), 125, 705–712
Hara, T., Kodama, H., Kondo, M., et al. (2001) Effects of peptide dimerization on pore formation: antiparallel disulfide-dimerized magainin 2 analogue, Biopolymers, 58, 437–446
Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., and Matsuzaki, K. (2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: praline as a translocation promoting factor, Biochemistry, 39, 8648–8654
Ganz, T. and Lehrer, R. I. (1995) Defensins, Pharmacol. Ther., 66, 191–205
Lehrer, R. I., Lichtenstein, A. K., and Ganz, T. (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells, Annu. Rev. Immunol., 11, 105–128
Tang, Y. Q., Yuan, J., Osapay, G., et al. (1999) A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins, Science, 286, 498–502
Hoover, D. M., Rajashankar, K. R., Blumenthal, R., et al. (2000) The structure of human beta-defensin-2 shows evidence of higher-order oligomerization, J. Biol. Chem., 275, 32911–32918
Pardi, A., Zhang, X. L., Selsted, M. E., Skalicky, J. J., and Yip, P. F. (1992) NMR studies of defensin antimicrobial peptides. 2. Three-dimmensional structures of rabbit NP-2 and human HNP-1, Biochemistry, 31, 11357–11364
Skalicky, J. J., Selsted, M. E., and Pardi, A. (1994) Structure and dynamics of neutrophil defensins NP-2, NP-5, and HNP-1: NMR studies of amide hydrogen exchange kinetics, Proteins, 20, {52–67}
Zimmermann, G. R., Legault, P., Selsted, M. E., and Pardi, A. (1995) Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins, Biochemistry, 34, 13663–13671
Sawai, M. V., Jia, H. P., Liu, L., et al. (2001) The NMR structure of human beta- defensin-2 reveals a novel alpha-helical segment, Biochemistry, 40, 3810–3816
Ganz, T., Selsted, M. E., Szklarek, D., et al. (1985) Defensins. Natural peptide antibiotics of human neutrophils, J. Clin. Invest., 76, 1427–1435
Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., and Lehrer, R. I. (1985) Primary structures of three human neutrophil defensins, J. Clin. Invest., 76, 1436–1439
Gabay, J. E., Scott, R. W., Campanelli, D., et al. (1989) Antibiotic proteins of human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. U.S.A., 86, 5610–5614.
Joiner, K. A., Ganz, T., Albert, J., and Rotrosen, D. (1989) The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes, J. Cell. Biol., 109, 2771–2782.
Porter, E. M., Liu, L., Oren, A., Anton, P. A., and Ganz, T. (1997) Localization of human intestinal defensin 5 in Paneth cell granules, Infect. Immun., 65, 2389–2395.
Bensch, K. W., Raida, M., Magert, H. J., Schulz-Knappe, P., and Forssmann, W. G. (1995) hBD-1: a novel beta-defensin from human plasma, FEBS Lett., 368, 331–335.
Zhao, C. Q., Wang, I., and Lehrer, R. I. (1996) Widespread expression of beta- defensin HBD-1 in human secretory glands and epithelial cells, FEBS Lett., 396, 319–322.
Harder, J., Bartels, J., Christophers, E., and Schröder, J. M. (1997) A peptide antibiotic from human skin, Nature, 387, 861–862.
Harder, J., Bartels, J., Christophers, E., and Schröder, J. M. (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic, J. Biol. Chem., 276, 5707–5713.
Diamond, G., Russell, J. P., and Bevins, C. L. (1996) Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelia cells, Proc. Natl. Acad. Sci., U.S.A., 93, 5156–5160.
Schonwetter, B. S., Stolzenberg, E. D., and Zasloff, M. A. (1995) Epithelial antibiotics induced at sites of inflammation, Science, 267, 1645–1648.
Diamond, G., Zasloff, M., Eck, H., et al. (1991) Tracheal antimicrobial peptide: a cystein-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA, Proc. Natl. Acad. Sci. U.S.A., 88, 3852–3956.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., and Selsted, M. E. (1989) Interaction of human defensins with Escherichia coli. Mechanism of bacterial activity, J. Clin. Invest., 84, 553–561.
Lehrer, R. I., Szklarek, D., Ganz, T., and Selsted, M. E. (1985) Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity, Infect. Immun., 49, 207–211.
Lehrer, R. I., Barton, A., and Ganz, T. (1988) Concurrent assessment of inner and outer membrane permeability and bacteriolysis in E. coli by multiple-wavelength spectrophotometry, J. Immunol. Methods, 108, 153–158.
Lichtenstein, A. K., Ganz, T., Nguyen, T. M., Selsted, M. E., and Lehrer, R. I. (1988) Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity, J. Immunol., 140, 2686–2694.
Lichtenstein, A., Ganz, T., Selsted, M. E., and Lehrer, R. I. (1986) In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes, Blood, 68, 1407–1410.
Wimley, W. C., Selsted, M. E., and White, S. H. (1994) Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores, Protein Sci., 3, 1362–1373.
White, S. H., Wimley, W. C., and Selsted, M. E. (1995) Structure, function, and membrane integration of defensins, Curr. Opin. Struct. Biol.. 5, 521–527.
Fujii, G., Selsted, M. E., and Eisenberg, D. (1993) Defensins promote fusion and lysis of negatively charged membranes, Protein Sci., 2, 1301–1312.
Kagan, B. L., Selsted, M. E., Ganz, T., and Lehrer, R. I. (1990) Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes, Proc. Natl. Acad. Sci. U.S.A., 87, 210–214.
Ganz, T., Metcalf, J. A., Gallin, J. I., Boxer, L. A., and Lehrer, R. I. (1988) Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and “specific” granule deficiency, J. Clin. Invest., 82, 552–556.
Gallin, J. I., Fletcher, M. P., Seligmann, B. E., et al. (1982) Human neutrophil- specific granule deficiency: a model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response, Blood, 59, 1317–1329.
Gombart, A. F., Shiohara, M., Kwok, S. H., et al. (2001) Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-epsilon, Blood, 97, 2561–2567.
Turner, J., Cho, Y., Dinh, N. N., Waring, A. J., and Lehrer, R. I. (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils, Antimicrob. Agents Chemother., 42, 2206–2214.
Zanetti, M., Gennaro, R., and Romeo, D. (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain, FEBS Lett., 374, 1–5.
Panyutich, A., Shi, J., Boutz, P. L., Zhao, C., and Ganz, T. (1997) Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins, Infect. Immun., 65, 978–985.
Scocchi, M., Skerlavaj, B., Romeo, D., and Gennaro, R. (1992) Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins, Eur. J. Biochem., 209, 589–595.
Zanetti, M., Litteri, L., Griffiths, G., Gennaro, R., and Romeo, D. (1991) Stimulus- induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides, J. Immunol., 146, 4295–4300.
Levy, O., Weiss, J., Zarember, K., Ooi, C. E., and Elsbach, P. (1993) Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins, J. Biol. Chem., 268, 6058–6063.
Zarember, K., Elsbach, P., Shin-Kim, K., and Weiss, J. (1997) p15s (15-kD antimicrobial proteins) are stored in the secondary granules of rabbit granulocytes: implications for antibacterial synergy with the bactericidal/permeability-increasing protein in inflammatory fluids, Blood, 89, 672–679.
Gudmundsson, G. H., Agerberth, B., Odeberg, J., et al. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes, Eur. J. Biochem., 238, 325–332.
Sorenson, O. E., Follin, P., Johnsen, A. H., et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3, Blood, 97, 3951–3959.
Oren, Z., Lerman, J. C., Gudmunsson, G. H., Agerberth, B., and Shai, Y. (1999) Structure and organization of the human antibacterial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity, Biochem. J., 341, 501–513.
De, Y., Chen, Q., Schmidt, A. P., et al. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL 1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T-cells, J. Exp. Med., 192, 1069–1074.
Frohm, N. M., Sandstedt, B., Sorensen, O., et al. (1999) The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epthelia and colocalizes with interleukin-6, Infect. Immun., 67, 2561–2566.
Bals, R., Wang, X., Zasloff, M., and Wilson, J. M. (1998) The peptide antibiotic LL-37/hCAP-18 is express in epithelia of the human lung where it has broad antimicrobial activity at the airway surface, Proc. Natl. Acad. Sci. U.S.A., 95, 9541–9546.
Malm, J., Sorensen, O., Persson, T., et al. (2000) The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa, Infect. Immun., 68, 4297–4302.
Islam, D., Bandholtz, L., Nilsson, J., et al. (2001) Downregulation of bacterial peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator, Nat. Med., 7, 180–185.
Bals, R., Weiner, D. J., Meegalla, R. L., and Wilson, J. M. (1999) Transfer of cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model, J. Clin. Invest., 103, 1113–1117.
Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., and Wilson, J. M. (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide, Infect. Immun., 67, 6084–6089.
Underhill, D. M. (2003) Innate immune signaling during phagocytosis. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 341–359.
Aderem, A. and Underhill, D. M. (1999) Mechanisms of phagocytosis in macrophages, Annu. Rev. Immunol., 17, 593–623.
Ernest, J. D. (2000) Bacterial inhibition of phagocytosis, Cell. Microbiol., 2, 279–386.
Greenberg, S. (1999) Modular components of phagocytosis, J. Leukoc. Biol., 66, 712–717.
Revetch, J. V. and Clynes, R. A. (1998) Divergent roles for Fc receptors and complement in vivo, Annu. Rev. Immunol., 16, 421–432.
Daeron, M. (1997) Fc receptor biology, Annu. Rev. Immunol., 15, 203–234.
Ross, G. D. (2000) Regulation of adhesion versus cytotoxic functions of the Mac- 1/CR3/alphaM-beta-2-integrin glycoprotein, Crit. Rev. Immunol., 20, 197–222.
Blystone, S. D. and Brown, E. J. (1999) Integrin receptors of phagocytes. In Phagocytosis: The Host (Gordon, S., ed.), JAI Press, Stamford, CT, pp. 102–147.
Dib, K. (2000) BETA 2 integrin signaling in leukocyes, Front. Biosci., 5, D438–D451.
Berger, M., O’Shea, J., Cross, A. S., et al. (1984) Human neutrophils increase expression of C3bi as well as C3b receptors upon activation, J. Clin. Invest., 74, 1566–1571.
Sengelov, H., Kjeldsen, L., Diamond, M. S., Springer, T. A., and Borregaard, N. (1993) Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils, J. Clin. Invest., 92, 1467–1476.
Jones, S. L., Knaus, U. G., Bokoch, G. M., and Brown, E. J. (1998) Two signaling mechanisms for activation of alphaM beta2 avidity in polymorphonuclear neutrophils, J. Biol. Chem., 273, 10556–10566.
Wroght, S. D. and Griffin, F. M., Jr. (1985) Activation of phagocytic cells’ C3 receptors for phagocytosis, J. Leukoc. Biol., 38, 327–339.
Wright, S. D., Craigmyle, L. S., and Silverstein, S. C. (1983) Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes, J. Exp. Biol., 158, 1338–1343.
Pommier, C. G., Inada, S., Fries, L. F., et al. (1983) Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes, J. Exp. Med., 157, 1844–1854.
Di Carlo, F. J. and Fiore, J. V. (1958) On the composition of zymosan, Science, 127, 756–757.
Lipke, P. N. and Ovalle, R. (1998) Cell wall architecture in yeast: new structure and new challenges, J. Bacteriol., 180, 3735–3740.
Sung, S. S., Nelson, R. S., and Silverstein, S. C. (1983) Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages, J. Cell. Biol., 96, 160–166.
Goldman, R. (1988) Characteristics of the beta-glucan receptor of murine macrophages, Exp. Cell. Res., 174, 481–490.
Janusz, M. J., Austen, K. F., and Czop, J. K. (1986) Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors, J. Immunol., 137, 3270–3276.
Giaimis, J., Lombard, Y., Fonteneau, P., et al. (1993) Both mannose and beta- glucan receptors are involved in the phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages, J. Leukoc. Biol., 54, 564–571.
Platt, N., Haworth, R., da Silva, R. P., and Goedon, S. (1999) Scavenger receptors and phagocytosis of bacteria and apoptotic cells. In: Phagocytosis: The Host (Gordon, S., ed.), JAI Press, Stamford, CT, pp. 71–85.
Peiser, L., Gough, P. J., Kodama, T., and Goedon, S. (2000) Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of the cell heterogeneity, microbial strain, and culture conditions in vitro, Infect. Immun., 68, 1953–1963.
Thomas, C. A., Li, Y., Kodama, T., et al. (2000) Protection from lethal gram- positive infection by macrophage scavenger receptor-dependent phagocytosis, J. Exp. Med., 191, 147–156.
Elomaa, O., Kangas, M., Sahlberg, C., et al. (1995) Cloning of a novel bacteria- binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages, Cell, 80, 603–609.
van der Laan, L. J., Dopp, E. A., and Haworth, R., et al. (1999) Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo, J. Immunol., 162, 939–947.
Placecanda, A., Paulauskis, J., Al-Mutairi, E., et al. (1999) Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles, J. Exp. Med., 189, 1497–1506.
Albert, M. L., Pearce, S. F., Francisco, L. M., et al. (1998) Immature dendritic cells phagocytose apoptotic cells via ανβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes, J. Exp. Med., 188, 1359–1368.
Fadok, V. A., Warner, M. L., Bratton, D. L., and Henson, P. M. (1998) CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor ανβ5, J. Immunol., 161, 6250–6257.
Franc, N. C., Heitzler, P., Ezekowitz, R. A., and White, K. (1999) Requirement for croquemort in phagocytosis of apoptotic cells in Drosophila, Science, 284, 1991–1994.
Allen, L. A. and Aderem, A. (1996) Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages, J. Exp. Med., 184, 627–637.
Allen, L. A. and Aderem, A. (1996) Mechanisms of phagocytosis, Curr. Opin. Immunol., 8, 36–40.
Crowley, M. T., Costello, P. S., Fitzer-Attas, C. J., et al. (1997) A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages, J. Exp. Med., 186, 1027–1039.
Kusner, D. J., Hall, C. F., and Schlesinger, L. S. (1996) Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages, J. Exp. Med., 184, 585–595.
Lin, T. H., Aplin, A. E., Shen, Y., Chen, Q., et al. (1997) Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts, J. Cell Biol., 136(6), 1385–1995.
Ip, Y. T. and Davis, R. J. (1998) Signal transduction by the c-Jun N-terminal kinase (JNK) – from inflammation to development, Curr. Opin. Cell. Biol., 10, 205–219.
Allen, L. H. and Aderem, A. (1995) A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages, J. Exp. Med., 182, 829–840.
Melendez, A. J., Harnett, M. M., and Allen, J. M. (1999) Differentiation-dependent switch in protein kinase C isoenzyme activation by FcgammaRI, the human high- affinity receptor for immunoglobulin G, Immunology, 96, 457–464.
Zheng, L., Zomerdijk, T. P., Aarnoudse, C., van Furth, R., and Nibbering, P. H. (1995) Role of protein kinase C isozymes in Fc gamma receptor-mediated intracellular killing of Staphylococcus aureus by human monocytes, J. Immunol., 155, 776–784.
Zheleznyak, A. and Brown, E. J. (1992) Immunoglobulin-mediated phagocytosis by human monocytes requires protein kinase C activation. Evidence for protein kinase C translocation to phagosomes, J. Biol. Chem., 267, 12042–12048.
Aderem, A. (1992) The MARCKS brothers: a family of protein kinase C substrates, Cell, 71, 713–716.
Shapira, L., Takashiba, S., Champagne, C., Amar, S., and van Dyke, T. E. (1992) Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes, J. Immunol., 153, 1818–1824.
Kovacs, E. J., Radzioch, D., Young, H. A., and Varesio, L. (1988) Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages, J. Immunol., 141, 3101–3105.
Huwiler, A. and Pfeilschifter, J. (1993) A role for protein kinase X-alpha in zymosan-stimulated eicosanoid synthesis in mouse peritoneal macrophages, Eur. J. Biochem., 217, 69–75.
Giroux, M. and Descoteaux, A. (2000) Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha, J. Immunol., 165, 3985–3991.
St-Denis, A., Chano, F., Tremblay, P., St-Pierre, Y., and Descoteaux, A. (1998) Protein kinase C-alpha modulates lipopolysaccharide-induced functions in a murine macrophage cell line, J. Biol. Chem., 273, 32787–32792.
St-Denis, A., Caouras, V., Gervais, F., and Descoteaux, A. (1999) Role of protein kinase C-alpha in the control of infection by intracellular pathogens in macrophages, J. Immunol., 163, 5505–5511.
Larsen, E. C., DiGennaro, J. A., Saito, N., et al. (2000) Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells, J. Immunol., 165, 2809–2817.
Botelho, R. J., Teruel, M., Dierckman, R., et al. (2000) Localized biphasic changes in phosphatidylinositol-4,5-biphosphate at sites of phagocytosis, J. Cell. Biol., 151, 1353–1368.
Chan, T. O., Rittenhouse, S. E., and Tsichlis, P. N. (1999) AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation, Annu. Rev. Biochem., 68, 965–1014.
Lennartz, M. R. (1999) Phospholipases and phagocytosis: the role of phospholipid- derived second messengers in phagocytosis, Int. J. Biochem. Cell. Biol., 31, 415–430.
Celli, J., Oliver, M., and Finlay, B. B. (2001) Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways, EMBO J., 20, 1245–1258.
Araki, N., Johnson, M. T., and Swanson, J. A. (1996) A role for phosphoinositide 3- kinase in the completion of macropinocytosis and phagocytosis by macrophages, J. Cell. Biol., 135, 1249–1260.
Gold, E. S., Underhill, D. M., Morrissette, N. S., et al. (1999) Dynamin 2 is required for phagocytosis in macrophages, J. Exp. Med., 190, 1849–1856.
Arbibe, L., Mira, J. P., Teusch, N., et al. (2000) Toll-like receptor 2-mediated NF- kappa B activation requires a Rac 1-dependent pathway, Nat. Immun., 1, 533–540.
Chimini, G. and Chavrier, P. (2000) Function of Rho family proteins in actin dynamics during phagocytosis and engulfment, Nat. Cell. Biol., 2, E191–E196.
Schmitz, A. A., Govek, E. E., Bottner, B., and van Aelst, L. (2000) Rho GTPases: signaling, migration, and invasion, Exp. Cell. Res., 261, 1–12.
Caron, E. and Hall, A. (1998) Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases, Science, 282, 1717–1721.
Massol, P., Montcourrier, P., Guillemot, J. C., and Chavrier, P. (1998) Fc receptor- mediated phagocytosis requires CDC42 and Rac1, EMBO J., 17, 6219–6229.
Guillen, N., Boquet, P., and Sansonetti, P. (1998) The small GTP-binding protein RacG regulates uroid formation in the protozoan parasite Entamoeba histolytica, J. Cell. Biol., 111, 1729–1739.
Cox, D., Chang, P., Zhang, Q., et al. (1997) Requirements for both Rac1 and Cdc42 in membrane ruffing and phagocytosis in leukocytes, J. Exp. Med., 186, 1487–1494.
Von Pawel-Rammingen, U., Telepnev, M.V., Schmidt, G., et al. (2000) GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure, Mol. Microbiol., 36, 737–748.
Goehring, U. M., Schmidt, G., Pederson, K. J., Aktories, K., and Barbieri, J. T. (1999) The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases, J. Biol. Chem., 274, 36369–36372.
Leusen, J. H. W., Verhoeven, A. J., and Roos, D. (1996) Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family, Front. Biosci., 1, 72–90.
DeLeo, F. R., Allen, L. A., Apicella, M., and Nauseef, W. M. (1999) NADPH oxidase activation and assembly during phagocytosis, J. Immunol., 163, 6732–6740.
Segal, A. W., Wientjes, F., Stockely, R. W., and Dekker, L. V. (1999) Components and organization of the NADPH oxidase of phagocytic cells. In: Phagocytosis: The Host (Gordon, S., ed.), JAI Press, Stamford, CT, pp. 441–483.
Wright, S. D. and Silverstein, S. C. (1983) Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes, J. Exp. Med., 158, 2016–2023.
Yamamoto, K. and Johnston, R. B., Jr. (1984) Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages, J. Exp. Med., 159, 405–416.
Berton, G. and Gordon, S. (1983) Modulation of macrophage mannosyl-specific receptors by cultivation on immobilized zymosan. Effects on superoxide-anion release and phagocytosis, Immunology, 49, 705–715.
Berton, G., Laudanna, C., Sorio, C., and Rossi, F. (1992) Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils, J. Cell. Biol., 116, 1007–1017.
Laudanna, C., Melotti, P., Bonizatto, C., et al. (1993) Ligation of members of the beta 1 or the beta 2 subfamilies of integrins by antibodies triggers eosinophil respiratory burst and spreading, Immunology, 80, 273–280.
Ozinsky, A., Underhill, D. M., Fontenot, J. D., et al. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors, Proc. Natl. Acad. Sci. U.S.A., 97, 13766–13771.
Underhill, D. M., Ozinsky, A., Hajjar, A. M., et al. (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens, Nature, 401, 811–815.
Boyce, J. A. and Austen, K. F. (2003) The role of mast cells in innate immunity. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 361–385.
McNeil, H. P. and Austen, K. F. (1995) Biology of the mast cell. In: Sampter’s Immunologic Diseases, 5th ed. (Frank, M. M., Austen, K. F., Claman, H. N., et al., eds.), Williams 8 Wilkins, Baltimore, MD, pp. 185–204.
Guy-Grant, D., Dy, M., Luffau, G., et al. (1984) Gut mucosal mast cells: origin, traffic and differentiaton, J. Exp. Med., 160, 12–28.
Gurish, M. F., Tao, H., Abonia, J. P., et al. 2001) Intestinal mast cell progenitor require CD49dβ7 (α4β7) for tissue-specific homing, J. Exp. Med., 194, 1243–1252.
Rosenkranz, A. R., Coxon, A., Maurer, M., et al. (1998) Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice, J. Immunol., 168, 6463–6467.
Tachimoto, H., Hudson, S. A., and Bochner, B. S. (2001) Acquisition and alteration of adhesion molecules during cultured human mast cell differentiation, J. Allergy Clin. Immunol., 107, 10–16.
Nilsson, G., Butterfield, J. H., Nilsson, K., and Siegbahn, A. (1994) Stem cell factor is a chemotactic factor for human mast cells, J. Immunol., 153, 3717–3723.
Meininger, C. J., Yano, H., Rottapel, R., et al. (1992) The c-kit receptor ligand functions as a mast cell chemoattractant, Blood, 79, 958–963.
Schwartz, L. B., Irani, A. M., Roller, K., et al. (1987) Quantitation of histamine, tryptase, and chymase in human T and TC mast cells, J. Immunol., 138, 2611–2615.
Benditt, E. P., Arase, M., and Roeper, M. E. (1956) Histamine and heparine in isolated rat mast cells, J. Histochem. Cytochem., 4, 419.
Leino, L. and Lilius, E.-M. (1990) Histamine receptors on leukocytes are expressed differently in vitro and ex vivo, Int. Arch. Allergy Appl. Immunol., 91, 30–35.
Falus, A. and Meretey, K. (1992) Histamine: an early messenger in inflammatory and immune reactions, Immunol. Today, 13, 154–156.
Schwartz, L. B., Lewis, R. A., and Austen, K. F. (1981) Tryptase from human pulmonary mast cells. Purification and characterization, J. Biol. Chem., 256, 11939–11943.
Schechter, N. M., Choi, J. K., Slavin, D. A., et al. (1986) Identification of a chymotrypsin-like proteinase in human mast cells, J. Immunol., 137, 962–970.
Pallaoro, M., Fejzo, M. S., Shayesteh, L., et al. (1999) Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3, J. Biol. Chem., 274(6), 3355–3362.
Schchter, N. M., Irani, A. M., Sprows, J. L., et al. (1990) Identification of cathepsin G-like proteinase in the MCTC type of human mast cell, J. Immunol., 145, 2652–2661.
Reynolds, D. S., Stevens, R. L., Gurley, D. S., et al. (1989) Isolation and molecular cloning of mast cell carboxypeptidase A: a novel member of the carboxypeptidase gene family, J. Biol. Chem., 264, 20094–20099.
Irani, A. M., Goldstein, S. M., Wintroub, B. U., et al. (1991) Human mast cell carboxypeptidase. Selective localization to MCTC cells, J. Immunol., 147, 247–253.
Irani, A. A., Schechter, N. M., Craig, S. S., et al. (1986) Two types of human mast cells that have distinct neutral protease compositions, Proc. Natl. Acad. Sci. U.S.A., 83, 4464–4468.
Irani, A. M., Craig, S., DeBlois, G., et al. (1987) Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function, J. Immunol., 138, 4381–4386.
Chandrasekharan, U. M., Sanker, S., Glynias, M. J., et al. (1996) Angiotensin II- forming activity in a reconstructed ancestral chymase, Science, 271, 502–505.
Sanker, S., Chandrasekharan, U. M., Wilk, D., et al. (1997) Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation, J. Biol. Chem., 272, 2963–2968.
Coussens, L. M., Raymond, W. W., Bergers, G., et al. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis, Genes Dev., 13, 1382–1397.
Kofford, M. W., Schwartz, L. B., Schechter, N. M., et al. (1997) Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide, J. Biol. Chem., 272, 7127–7131.
Longley, B. J., Tyrrell, L., Ma, Y., et al. (1997) Chymase cleavage of stem cell factor yields a bioactive, soluble product, Proc. Natl. Acad. Sci. U.S.A., 94, 9017–9021.
Reynolds, D. S., Gurley, D. S., Stevens, R. L., et al. (1989) Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases, Proc. Natl. Acad. Sci. U.S.A., 86(23), 9480–9484.
Caughey, G. H. (1989) Roles of mast cell tryptase and chymase in airway function, Am. J. Physiol., 257, L39.
Humphries, D. E., Nicodemus, C. F., Schiller, V., et al. (1992) The human serglycin gene. Nucleotide sequence and methylation pattern in human promyelitic leukemia HL-60 cells and T-lymphoblast Molt-4 cells, J. Biol. Chem., 267, 13558–13563.
Avraham, S., Stevens, R. L., Gartner, M. C., et al. (1988) Isolation of a cDNA that encodes the peptide core of the secretory proteoglycan of rat basophilic leukemia-1 cells and assessment of its homology to the human analogue, J. Biol. Chem., 263, 7292–7296.
Avraham, S., Stevens, R. L., Nicodemus, C. F., et al. (1989) Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cDNA, Proc. Natl. Acad. Sci. U.S.A., 86, 3763–3767.
Metcalfe, D. D., Soter, N. A., Wasserman, S. I., et al. (1980) Identification of sulfated mucopolysaccharides including heparin in the lesional skin of a patient with systemic mastocytosis, J. Invest. Dermatol., 74, 210–215.
Metcalfe, D. D., Lewis, R. A., Silbert, J. E., et al. (1979) Isolation and characterization of heparin from human lung, J. Clin. Invest., 64, 1537–1543.
Stevens, R. L., Fox, C. C., Lichtenstein, L. M., et al. (1988) Identification of chondroitin sulfate E proteoglycans in the secretory granules of human lung mast cells, Proc. Natl. Acad. Sci. U.S.A., 85, 2284–2287.
Eliakim, R., Gilead, L., Ligumsky, M., et al. (1986) Possible presence of E-mast cells in the human colon, Proc. Natl. Acad. Sci. U.S.A., 83, 461–464.
Schwartz, L. B., Riedel, C., Caufield, J. P., et al. (1981) Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells, J. Immunol., 126, 2071–2078.
Schwartz, L. B., Riedel, C., Schratz, J. J., et al. (1982) Localization of carboxypeptidase A to the macromolecular heparin proteoglycan-protein complex in secretory granules of rat serosal mast cells, J. Immunol., 128, 1128–1133.
Serafin, W. E., Katz, H. R., Austen, K. F., et al. (1986) Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H] diisopropyl fluorophosphates-binding proteins are exocytosed from activated mouse bone marrow-mast cells, J. Biol. Chem., 261, 15017–15021.
Goldstein, S. M., Leong, J., Schwartz, L. B., et al. (1992) Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes, J. Immunol., 148, 2475–2482.
Paterson, N. A. M., Wasserman, S. I., Said, J. W., et al. (1976) Release of chemical mediators from partially purified human lung mast cells, J. Immunol., 117, 1356–1362.
Heavey, D. J., Ernst, P. B., Stevens, R. L., et al. (1988) Generation of leukotriene C4, leukotriene B4 and prostaglandin D2 by immunologically activated rat intestinal mucosal mast cells, J. Immunol., 140, 1953–1957.
Murakami, M., Austen, K. F., and Arm, J. P. (1995) The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase, J. Exp. Med., 182, 197–206.
Columbo, M., Horowitz, E. M., Botana, L. M., et al. (1992) The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and peripheral blood basophils, J. Immunol., 149, 599–608.
Clark, J. D., Lin, L.-L., Kriz, R. W., et al. (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP, Cell, 65, 1043–1051.
Malavia, R., Malavia, R., and Jakschik, B. A. (1993) Reversible translocation of 5- lipoxygenase in mast cells upon IgE/antigen stimulation, J. Biol. Chem., 268, 4939–4944.
Dixon, R. A. F., Diehl, R. E., Opas, E., et al. (1990) Requirement of a 5- lipoxygenase-activating protein for leukotriene biosynthesis, Nature, 343, 282–284.
Evans, J. F., Dupuis, P., and Ford-Hutchinson, A. W. (1985) Purification and characterization of leukotriene A4 hydrolase from rat neutrophils, Biochem. Biophys. Acta, 840, 43–50.
Lam, B. K., Penrose, J. F., Freeman, G. J., et al. (1994) Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4, Proc. Natl. Acad. Sci. U.S.A., 91, 7663–7667.
Lam, B. K., Gagnon, L., Austen, K. F. et al. (1990) The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes, J. Biol. Chem., 265, 13438–13441.
Lam, B. K., Xu, K., Atkins, M. B., et al. (1992) Leukotriene C4 uses a probenicid-sensitive export carrier that does not recognize leukotriene B4, Proc. Natl. Acad. Sci. U.S.A., 89, 11598–11602.
Lindbom, L., Hedqvist, P., Dahlen, S. E., et al. (1982) Leukotriene B4 induces extravasation and migration of polymorphonuclear leukocytes in vivo, Acta Physiol. Scand., 116, 105–108.
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997) A G- protein-coupled receptor for leukotriene B4 that mediates chemotaxis, Nature, 387, 620–624.
Yokomizu, T., Kato, K., Terawaki, K., Izumi, T., and Shimizu, T. (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders, J. Exp. Med., 192, 421–432.
Raulf, M., Stuning, M., and Konig, W. (1985) Metabolism of leukotrienes by L- gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes, Immunology, 55, 135–147.
Davidson, A. B., Lee, T. H., Scanlon, P. D., et al. (1987) Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects, Am. Rev. Respir. Dis., 135, 333–337.
Griffin, M., Weiss, J. W., Leitch, A. G., et al. (1983) Effect of leukotriene D4 on the airways in asthma, N. Engl. J. Med., 308, 436–439.
Laitinen, L. A., Laitinen, A., Haahtela, T., et al. (1993) Leukotriene E4 and granulocytic infiltration into asthmatic airways, Lancet, 341, 989–990.
Lynch, K. R., O’Neill, G. P., Liu, Q., et al. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor, Nature, 399, 789–793.
Heise, C. E., O’Dowd, B. F., Figueroa, D. J., et al. (2000) Characterization of the human cysteinyl leukotriene 2 receptor, J. Biol. Chem., 275, 30531–30536.
Mellor, E. A., Maekawa, A., Austen, K. F., and Boyce, J. A. (2001) Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells, Proc. Natl. Acad. Sci. U.S.A., 98, 7964–7969.
Kanaoka, Y., Maekawa, A., Penrose, J. F., Austen, K. F., and Lam, B. K. (2001) Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase, J. Biol. Chem., 276, 22608–22613.
Murakami, M., Matsumoto, R., Urade, Y., et al. (1995) c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase 1, and hematopoietic prostaglandin D2 synthase and increased IgE- dependent PGD2 generation in immature mouse mast cells, J. Biol. Chem., 270, 3239–3246.
Liu, M. C., Bleecker, E. R., Lichtenstein, L. M., et al. (1990) Evidence for elevated levels of histamine, prostaglandin D2 and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma, Am. Rev. Respir. Dis., 142, 126–132.
Roberts, L. J., II, Seibert, K., Liston, T. E., et al. (1987) PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings, Adv. Prostaglandin Thromboxane Leukotr. Res., 17A, 427–429.
Hirai, H., Tanaka, K., Yoshie, O., et al. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven- transmembrane receptor CRTH2, J. Exp. Med., 193, 255–261.
Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M., and Abramovitz, M. (1995) Molecular cloning and characterization of the human prostanoid DP receptor, J. Biol. Chem., 270, 18910–18916.
Gordon, J. R. and Galli, S. J. (1990) Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin, Nature, 346, 274–276.
Subramanian, N. and Bray, M. A. (1987) Interleukin 1 releases histamine from human basophils and mast cells in vitro, J. Immunol., 138, 271–274.
Lu-Kuo, J. M., Austen, K. F., and Katz, H. R. (1996) Post-transcriptional stabilization by interleukin-1β of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells, J. Biol. Chem., 271, 22169–22174.
Gagari, E., Tsai, M., Lantz, C. S., et al. (1997) Differential release of mast cell interleukin-6 via c-kit, Blood, 89, 2654–2663.
Walsh, L. J., Trinchieri, G., Waldorf, H. A., et al. (1991) Human dermal mast cells contain and release tumor nectosis factor α, which induces endothelial leukocyte adhesion molecule 1, Proc. Natl. Acad. Sci., U.S.A., 88, 4220–4224.
Bradding, P., Mediwake, R., Feather, I. H., et al. (1995) TNF-α is localized to nasal mucosal mast cells and is released in acute allergic rhinitis, Clin. Exp. Allergy, 25, 406–415.
Bradding, P., Roberts, J. A., Britten, K. M., et al. (1994) Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines, Am. J. Respir. Cell. Mol. Biol., 10, 471–480.
Echtenacher, B., Mannel, D. N., and Hultner, L. (1996) Critical protective role of mast cells in a model of acute septic peritonitis, Nature, 381, 75–79.
Barata, L. T., Ying, S., Meng, Q., et al. (1998) IL-4 and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects, J. Allergy Clin. Immunol., 101, 222–230.
Bradding, P., Feather, I. H., Wilson, S., et al. (1993) Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitis subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation, J. Immunol., 151, 3853–3865.
Ochi, H., Hirani, W. M., Yuan, Q., et al. (1999) T helper type-2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro, J. Exp. Med., 190, 267–280.
Okayama, Y., Semper, A., Holgate, S. T., and Church, M. K. (1995) Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI, Int. Arch. Allergy Immunol., 107, 158–159.
Grutzkau, A., Kruger-Krasagakes, S., Kogel, H., et al. (1997) Detection of intracellular interleukin-β in human mast cells: flow cytometry as a guide for immunoelectron microscopy, J. Histochem. Cytochem., 45, 935–945.
Moller, A., Lippert, U., Lessmann, D., et al. (1993) Human mast cells produce IL-8, J. Immunol., 151, 3261–3266.
Yano, K., Yamaguchi, M., de Mora, F., et al. (1977) Production of macrophage inflammatory protein-1 alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability, Lab. Invest., 77, 185–193.
Baghestanian, M., Hofbauer, R., Kiener, H. P., et al. (1997) The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells, Blood, 90, 4438–4449.
Hogaboam, C., Kunkel, S. L., Strieter, R. M., et al. (1998) Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions, J. Immunol., 160, 6166–6171.
Boesiger, J., Tsai, M., Maurer, M., et al. (1998) Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of FcεI expression, J. Exp. Med., 188, 1135–1145.
Kanbe, N., Kurosawa, M., Nagata, H., et al. (1999) Cord blood-derived human cultured mast cells produce transforming growth factor β1, Clin. Exp. Allergy, 29, 105–113.
Reed, J. A., Albino, A. P., and McNutt, N. S. (1995) Human cutaneous mast cells express basic fibroblast growth factor, Lab. Invest., 72, 215–222.
Zhang, S., Anderson, D. F., Bradding, P., et al. (1998) Human mast cells express stem cell factor, J. Pathol., 186, 59–66.
de Paulis, A., Minopoli, G., Arbustini, E., et al. (1999) Stem cell factor is localized in, released from, and cleaved by human mast cells, J. Immunol., 163, 2799–2808.
Sher, A., Hein, A., Moser, G., and Caulfield, J. P. (1979) Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells, Lab. Invest., 41, 490–499.
Zhang, Y., Ramos, B. F., and Jaschik, B. A. (1992) Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis, Science, 258, 1957–1959.
Malaviya, R., Ikeda, T., Ross, E., et al. (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha, Nature, 381, 77–80.
Maurer, M., Echtenacher, B., Hulktner, L., et al. (2001) the c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells, J. Exp. Med., 188, 2343–2348.
Lorentz, A., Schwengberg, S., Sellge, G., et al. (2000) Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4, J. Immunol., 164, 43–48.
Ochi, H., De Jesus, N. H., Hsieh, F., Austen, K. F., and Boyce, J. A. (2000) Interleukins 4 and 5 prime human mast cells for different profiles of IgE-dependent cytokine production, Proc. Natl. Acad. Sci. U.S.A., 97, 10509–10513.
Huang, C., Friend, D. S., Qui, W. T., et al. (1998) Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6, J. Immunol., 160, 1910–1919.
Huang, C., De Sanctis, G. T., O’Brien, P. J., et al. (2001) Evaluation of the substrate specificity of human mast cell tryptase beta 1 and demonstration of its importance in bacterial infections of the lung, J. Biol. Chem., 276, 26276–26284.
Malaviya, R., Navara, C., and Uckun, F. M. (2001) Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria, Immunity, 18, 313–321.
Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J., and Carroll, M. C. (1997) Impaired mast cell-dependent natural immunity in complement C3-deficient mice, Nature, 390, 172–175.
Gommerman, J. L., Oh, D. Y., Zhou, X., et al. (2000) A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation, J. Immunol., 165, 6915–6921.
Artis, D., Humphreys, N. E., Potten, C. S., et al. (2000) β7 Integrin-deficient mice: delayed leukocyte recruitment and attenuated protective imminity in the small intestine during enteric helminth infection, Eur. J. Immunol., 30, 1656–1664.
Moody, D. B. (2003) CD1-restricted T-cells. In: Innate Immunity (Ezekowitz, R. A. B. and Hoffmann, J. A., eds.), Humana Press, Totowa, NJ, pp. 387–402.
Garcia, K. C., Degano, M., Stanfield, R. L., et al. (1996) An alpha beta T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex, Science, 274, 209–219.
Porcelli, S. A. (1995) The CD1 family: a third lineage of antigen-presenting molecules, Adv. Immunol., 59, 1–98.
Calabi, F. and Milstein, C. (1986) A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6, Nature, 323, 540–543.
Beckman, E. M., Porcelli, S. A., Morita, C. T., et al. (1994) Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells, Nature, 372, 691–694.
Sieling, P. A., Chatterjee, D., Porcelli, S. A., et al. (1995) CD1-restricted T cell recognition of microbial lipoglycan antigens, Science, 269, 227–230.
Moody, D. B., Reinhold, B. B., Guy, M. R., et al. (1997) Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells, Science, 278, 283–286.
Kawano, T., Cui, J., Koezuka, Y., et al. (1997) CD1d-restricted and TCR-mediated activation of Vα 14 NKT cells by glycosylceramides, Science, 278, 1626–1629.
Porcelli, S., Morita, C. T., and Brenner, M. B. (1992) CD1b restricts the response of human CD4–8– T lymphocytes to a microbial antigen, Nature, 360, 593–597.
Koseki, H., Imai, K., Nakayama, F., et al. (1990) Homogenous junctional sequence of the V 14+ T-cell antigen receptor alpha chain expanded in unprimed mice, Proc. Natl. Acad. Sci. U.S.A., 180, 5248–5252.
Lantz, O. and Bendelac, A. (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4–8– T cells in mice and humans, J. Exp. Med., 180, 1097–1106.
Porcelli, S., Gerdes, D., Fertig, A. M., and Balk, S. P. (1996) Human T cells expressing an invariant V alpha 24-J alpha Q TCR alpha are CD4- and heterogeneous with respect to TCR beta expression, Hum. Immunol., 48, 63–67.
Medzhitov, R. and Janeway, C. A., Jr. (1997) Innate immunity: the virtues of a nonclonal system of recognition, Cell, 91, 295–298.
Park, S. H., Chiu, Y. H., Jayawardena, J., et al. (1998) Innate and adaptive functions of the CD1 pathway of antigen presentation, Semin. Immunol., 10, 391–398.
Grant, E. P., Degano, M., Rosat, J. P., et al. (1999) Molecular recognition of lipid antigens by T cell receptors, J. Exp. Med., 189, 195–205.
Cardell, S., Tangri, S., Chan, S., et al. (1995) CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice, J. Exp. Med., 182, 993–1004.
Behar, S. M., Podrebarac, T. A., Roy, C. J., Wang, C. R., and Brenner, M. B. (1999) Diverse TCRs recognize murine CD1, J. Immunol., 162, 161–167.
Moody, D. B., Besra, G. S., Wilson, I. A., and Porcelli, S. A. (1999) The molecular basis of CD1-mediated presentation of lipid antigens, Immunol. Rev., 172, 285–296.
Moore, P. F., Schrenzel, M. D., Affolter, V. K., Olivry, T., and Naydan, D. (1996) Canine cutaneous histiocytoma is an epidermotrophic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules, Am. J. Pathol., 148, 1699–1708.
Dascher, C. C., Hiromatsu, K., Naylor, J. W., et al. (1999) Conservation of a CD1 multigene family in the guinea pig, J. Immunol., 163, 5478–5488.
Woo, J. C. and Moore, P. F. (1997) A feline homologue of CD1 is defined using a feline-specific monoclonal antibody, Tissue Antigens, 49, 244–251.
Ichimiya, S., Kikuchi, K., and Matsuura, A. (1994) Structural analysis of the rat homologue of CD1. Evidence for evolutionary conservation of the CD1D class and widespread transcription by rat cells, J. Immunol., 153, 1112–1123.
Calabi, F., Belt, K. T., Yu, C. Y., et al. (1989) The rabbit CD1 and the evolutionary conservation of the CD1 gene family, Immunogenetics, 30, 370–377.
Sugita, M., Moody, D. B., Jackman, R. M., et al. (1998) CD1-a new paradigm for antigen presentation and T cell activation, Clin. Immunol. Immunopathol., 87(1), 8–14.
Bradbury, A., Belt, K. T., Neri, T. M., Milstein, C., and Calabi, F. (1988) Mouse CD1 is distinct from and co-exists with TL in the same thymus, EMBO J., 7, 3081–3086.
MacHugh, N. D., Bensaid, A., Davis, W. C., et al. (1988) Characterization of a bovine thymic differentiation antigen analogous to CD1 in the human, Scand. J. Immunol., 27, 541–547.
Dutia, B. M. and Hopkins, J. (1991) Analysis of the CD1 cluster in sheep, Vet. Immunol. Immunopathol., 27, 189–194.
Calabi, F., Jarvis, J. M., Martin, L., and Milstein, C. (1989) Two classes of CD1 genes, Eur. J. Immunol., 19, 285–292.
Angenieux, C., Salamero, J., Fricker, D., et al. (2000) Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells, J. Biol. Chem., 275, 37757–37764.
Mirones, I., Oteo, M., Parra-Cuadrado, J. F., and Martinez-Naves, E. (2000) Identification of two novel human CD1E alleles, Tissue Antigens, 56, 159–161.
Rosat, J. P., Grant, E. P., Beckman, E. M., et al. (1999) CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool, J. Immunol., 162, 366–371.
Beckman, E. M., Melian, A., Behar, S. M., et al. (1996) CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family, J. Immunol., 157, 2795–2803.
Han, M., Hannick, L. I., DiBrino, M., and Robinson, M. A. (1999) Polymorphism of human CD1 genes, Tissue Antigens, 54, 122–127.
Bauer, A., Huttinger, R., Staffler, G., et al. (1997) Analysis of the requirement for beta 2-microglobulin for expression and formation of human CD1 antigens, Eur. J. Immunol., 27, 1366–1373.
Gadola, S. D., Zaccai, N. R., Harlos, K., et al. (2002) Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains, Nat. Immunol., 3, 721–726.
Zeng, Z., Castaño, A. R., Segelke, B. W., et al., (1997) Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove, Science, 277, 339–345.
Moody, D. B., Ulrich, T., Muhlecker, W., et al. (2000) CD1c-mediated T cell recognition of mycobacterial glycolipids in M. tuberculosis infection, Nature, 404, 884–888.
Shamshiev, A., Donda, A., Carena, I., et al. (1999) Self glycolipids as T-cell autoantigens, Eur. J. Immunol., 29, 1667–1675.
Gumperz, J., Roy, Makowska, A., et al. (2000) Murine CD1d-restricted T cell recognition of cellular lipids, Immunity, 12, 211–221.
Schofield, L., McConville, M. J., Hansen, D., et al. (1999) CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells, Science, 283, 225–229.
Castaño, A. R., Tangri, S., Miller, J. E., et al. (1995) Peptide binding and presentation by mouse CD1, Science, 269, 223–226.
Brossay, L., Naidenko, O., Burdin, N., et al. (1998) Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells, J. Immunol., 161, 5124–5128.
Park, S. H., Weiss, A., Benlagha, K., et al. (2001) The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families, J. Exp. Med., 193, 893–904.
Benlagha, K., Weiss, A., Beavis, A., Teyton, L., and Bendelac, A. (2000) In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers, J. Exp. Med., 191, 1895–1903.
Matsuda, J. L., Naidenko, O. V., Gapin, L., et al. (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers, J. Exp. Med., 192, 741–754.
Porcelli, S. A. (1995) The CD1 family: a third lineage of antigen-presenting molecules, Adv. Immunol., 59, 1–98.
Sugita, M., Grant, E. P., van Donselaar, E., et al. (1999) Separate pathways for antigen presentation by CD1 molecules, Immunity, 11, 743–752.
Sugita, M., Jackman, R. M., van Donselaar, E., et al. (1996) Cytoplasmic tail- dependent localization of CD1b antigen-presenting molecules to MIICs, Science, 273, 349–352.
Sugita, M., van der Wel, N., Rogers, R. A., Petters, P. J., and Brenner, M. B. (2000) CD1c molecules broadly survey the endocytic system, Proc. Natl. Acad. Sci. U.S.A., 97, 8445–8450.
Briken, V., Jackman, R. M., Watts, G. F., Rogers, R. A., and Porcelli, S. A. (2000) Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens, J. Exp. Med., 192, 281–288.
Jackman, R. M., Stenger, S., Lee, A., et al. (1998) The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens, Immunity, 8, 341–351.
Jayawardena-Wolf, J., Benlagha, K., Chiu, Y. H., Mehr, R., and Bendelac, A. (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain, Immunity, 15, 897–908.
Bonifacino, J. S. and Dell’Angelica, E. C. (1999) Molecular bases for the recognition of tyrosine-based sorting signals, J. Cell. Biol., 145, 923–926.
Briken, V., Moody, D. B., and Porcelli, S. A. (2000) Diversification of CD1 proteins: sampling the lipid content of different cellular compartments, Semin. Immunol., 12, 517–525.
Moody, D. B. and Porcelli, S. A. (2001) CD1 trafficking invariant chain gives a new twist to the tale, Immunity, 15(6), 861–865.
Sugita, M., Peters, P. J., and Brenner, M. B. (2000) Pathways for lipid antigen presentation by CD1 molecules: nowhere for intracellular pathogens to hide, Traffic, 1, 295–300.
Moody, D. B., Reinhold, B. B., Reinhold, V. N., Besra, G. S., and Porcelli, S. A. (1999) Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells, Immunol. Lett., 65, 85–91.
Chiu, Y. H., Jayawardena, J., Weiss, A., et al. (1999) Distinct subsets of DC1d- restricted T cells recognize self-antigens loaded in different cellular compartments, J. Exp. Med., 189, 103–110.
Spada, F. M., Koezuka, Y., and Porcelli, S. A. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells, J. Exp. Med., 188, 1529–1534.
Moody, D. B., Briken, V., Cheng, T. Y., et al. (2002) Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation, Nat. Immunol., 3, 435–442.
Bendelac, A., Killeen, N., Littman, D. R., and Schwartz, R. H. (1994) A subset of CD4+ thymocytes selected by MHC class I molecules, Science, 263, 1774–1778.
Beutner, U., Launois, P., Ohteki, T., Louis, J. A., and MacDonald, H. R. (1997) Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production, Eur. J. Immunol., 27, 928–934.
Asea, A. and Stein-Streilein, J. (1998) Signaling through NK1.1 triggers NK cells to die but induces NK T cells to produce interleukin-4, Immunology, 93, 296–305.
Bendelac, A., Lantz, O., Quimby, M. E., et al. (1995) CD1 recognition by mouse NK1+ T lymphocytes, Science, 268, 863–865.
Smiley, S. T., Kaplan, M. H., and Grusby, M. J. (1997) Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells, Science, 275, 977–979.
Gapin, L., Matsuda, J. L., Surh, C. D., and Kronenberg, M. (2001) NKT cells derive from double-positive thymocytes that are positively selected by CD1d, Nat. Immunol., 2, 971–978.
Coles, M. C. and Raulet, D. H. (2000) NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells, J. Immunol., 164, 2412–2418.
Shimamura, M., Ohteki, T., Beutner, U., and MacDonald, H. R. (1997) Lack of directed V alpha 14-J alpha 281 rearrangement in NK1+ T cells, Eur. J. Immunol., 27, 1576–1579.
Mendiratta, S. K., Martin, W. D., Hong, S., et al. (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4, Immunity, 6, 469–477.
Chen, Y. H., Chiu, N. M., Mandal, M., Wang, N., and Wang, C. R. (1997) Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice, Immunity, 6, 459–467.
Joyce, S., Woods, A. S., Yewdell, J. W. (1998) Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol, Science, 279, 1541–1544.
Molano, A., Park, S. H., Chiu, Y. H., et al. (2000) Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPI in NK T cell activation and antimalarial responses, J. Immunol., 164, 5005–5009.
Romero, J. F., Eberl, G., MacDonald, H. R., and Corradin, G. (2001) CD1d- restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice, Parasite Immunol., 23, 267–269.
Kawano, T., Nakayama, T., Kamada, N., et al. (1999) Antitumor toxicity mediated by ligand-activated human V alpha24 NKT cells, Cancer Res., 59, 5102–5105.
Miyamoto, K., Miyake, S., Yamamura, T. (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer cells, Nature, 413, 531–534.
Hong, S., Wilson, M. T., Serizawa, I., et al. (2001) The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice, Nat. Med., 7, 1052–1056.
Sharif, S., Arreaza, G. A., Zucker, P., et al. (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes, Nat. Med., 7, 1057–1062.
Shi, F. D., Flodstrom, M., Balasa, B., et al. (2001) Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse, Proc. Natl. Acad. Sci. U.S.A., 98, 6777–6782.
Wang, B., Geng, Y. B., and Wang, C. R. (2001) CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes, J. Exp. Med., 194, 313–320.
Behar, S. M., Porcelli, S. A., Beckman, E. M., and Brenner, M. B. (1995) A pathway of costimulation that prevents anergy in CD28-T cells: B7-independent costimulation of CD1-restricted T cells, J. Exp. Med., 182, 2007–2018.
Pal, E., Tabira, T., Kawano, T., et al. (2001) Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells, J. Immunol., 166, 662–668.
Barry, C. E., Lee, R. E., Mdluli, K., et al. (1998) Mycolic acids: structure, biosynthesis and physiological functions, Prog. Lipid Res., 37, 143–179.
Bhardwaj, N., Friedman, S. M., Cole, B. C., and Nisanian, A. J. (1992) Dendritic cells are potent antigen-presenting cells for microbial superantigens, J. Exp. Med., 175, 267–273.
Sieling, P. A., Jullien, D., Dahlem, M., et al. (1999) CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity, J. Immunol., 162, 1851–1858.
Stenger, S., Hanson, D. A., Teitelbaum, R., et al. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin, Science, 282, 121–125.
Stenger, S., Mazzaccaro, R. J., Uyemura, K., et al. (1997) Differential effects of cytolytic T cell subsets on intracellular infection, Science, 276, 1684–1687.
Starnes, T., Broxmeyer, H. E., Robertson, M. J., and Hromas, R. (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis, J. Immunol., 169, 642–646.
Thomson, A. W. (1998) The Cytokine Handbook, 3rd ed., Academic Press, San Diego, CA, p. xxii; 1017.
Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F., and Golstein, P. (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene, J. Immunol., 150, 5445–5456.
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., and Armitage, R. J. (1995) Human IL-17: a novel cytokine derived from T cells, J. Immunol., 155, 5483–5486.
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A. M., Painter, S. L., Comeau, M. R., Cohen, J. I., and Spriggs, M. K. (1995) Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor, Immunity, 3(6), 811–821.
Yao, Z., Spriggs, M. K., Derry, J. M., Strockbine, L., Park, L. S., VandenBos, T., Zappone, J. D., Painter, S. L., and Armitage, R. J. (1997) Molecular characterization of the human interleukin (IL)-17 receptor, Cytokine, 9, 794–800.
Weaver, C. T., Hatton, R. D., Mangan, P. R., and Harrington, L. E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages, Annu. Rev. Immunol., 25, 821–852.
Kolls, J. K. and Linden, A. (2004) Interleukin-17 family members and inflammation, Immunity, 21, 467–476.
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., et al. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo, Immunity, 15, 985–995.
Hymowitz, S. G., Filvaroff, E. H., Yin, J. P., Lee, J., Cai, L., et al. (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding, EMBO J., 20(19), 5332–5341.
Li, H., Chen, J., Huang, A., Stinson, J., Heldens, S., Foster, J., et al. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family, Proc. Natl. Acad. Sci. U.S.A., 97(2), 773–778.
Shi, Y., Ullrich, S. J., Zhang, J., Connolly, K., et al. (2000) A novel cytokine receptor-ligand pair: identification, molecular characterization, and in vivo immunomodulatory activity, J. Biol. Chem., 275(25), 19167–19176.
Lee, J., Ho, W. H., Maruoka, M., Corpuz, R. T., Baldwin, D. T., et al. (2001) IL- 17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1, J. Biol. Chem., 276(2), 1660–1664.
Starnes, T., Robertson, M. J., Sledge, G., Kelich, S., Nakshatri, H., et al. (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production, J. Immunol., 167, 4137–4140.
Kawaguchi, M., Onuchic, L. F., Li, X. D., Essayan, D. M., Schroeder, J., et al. (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma, J. Immunol., 167, 4430–4435.
Aggarwal, S. and Gurney, A. L. (2002) IL-17: prototype member of an emerging cytokine family, J. Leukocyte Biol., 71, 1–8.
Fossiez, F., Banchereau, J., Murray, R., Van Kooten, C., Garrone, P., and Lebecque, S. (1998) Interleukin-17, Int. Rev. Immunol., 16(5–6), 541–551.
Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., and Pelletier, J. P. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-⍺, by human macrophages, J. Immunol., 160, 3513–3521.
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., et al. (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, J. Exp. Med., 183, 2593–2603.
Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de Roo, C. J. J., Joosten, L. A. B., and van den Berg, W. B. (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of colagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erasion, Arthritis Rheum., 50(2), 650–659.
Antonysamy, M. A., Fanslow, W. C., Fu, F., Li, W., Qian, S., Troutt, A. B., and Thomson, A. W. (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors, J. Immunol., 162, 577–584.
Van Kooten, C., Boonstra, J. G., Paape, M. E., Fossiez, F., Banchereau, J., et al. (1998) Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection, J. Am. Soc. Nephrol., 9, 1526–1534.
Kurusawa, K., Hirose, K., Sano, H., Endo, H., Shinkai, H., Nawata, Y., et al. (2000) Increased interleukin-17 production in patients with systemic sclerosis, Arthritis Rheum., 43, 2455–2463.
Matsumoto K. and Kanmatsuse, K. (2002) Increased urinary excretion of interleukin-17 in nephrotic patients, Nephron, 91, 243–249.
Wong, C. K., Ho, C. Y., Li, E. K., and Lam, C. W. (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus, Lupus, 9(8), 589–593.
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., et al. (1999) IL- 17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J. Clin. Invest., 103, 1345–1352.
Chabaud, M., Garnero, P., Dayer, J. M., Guerne, P. A., Fossiez, F., and Miossec, P. (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis, Cytokine, 12(7), 1092–1099.
Tartour, E., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E., et al. (1999) Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, Cancer Res., 59, 3698–3704.
Hirahara, N., Nio, Y., Sasaki, S., Minari, Y., Takamura, M., et al. (2001) Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice, Oncology, 61(1), 79–89.
Schwandner, R., Yamaguchi, K., and Cao, Z. (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF) 6 in interleukin 17 signal transduction, J. Exp. Med., 191, 1233–1240.
Tian, E., Sawyer, J. R., Largaespada, D. A., Jenkins, N. A., Copeland, N.G., and Shaughnessy, J. D., Jr. (2000) Evi27 encodes a novel membrane protein with homology to the IL17 receptor, Oncogene, 19, 2098–2109.
Haudenschild, D., Moseley, T., Rose, L., and Reddi, A. H. (2002) Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer, J. Biol. Chem., 277, 4309–4316.
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense, J. Exp. Med., 194, 519–527.
Kramer, J. M., Yi, L., Shen, F., Maitra, A., Jiao, X., et al. (2006) Evidence for ligand-independent multimerization of the IL-17 receptor, J. Immunol., 176, 711–715.
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., and Peschon, J. (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex, J. Immunol., 177, 36–39.
Sredni, B., Tse, H. Y., and Schwartz, R. H. (1980) Direct cloning and extended culture of antigen-specific MHC-restricted, proliferating T lymphocytes, Nature, 283, 581–583.
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol., 136, 2348–2357.
Coffman, R. L. and Carty, J. (1986) A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ, J. Immunol., 136, 949–954.
Mosmann, T. R. and Coffman, R. L. (1987) Two types of mouse helper T-cell clone, Immunol. Today, 8, 223–227.
Fernandez-Botran, R., Sanders, V. M., Mosmann, T. R., and Vitetta, E. S. (1988) Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells, J. Exp. Med., 168, 543–558.
Gajewski, T. F. and Fitch, F. W. (1988) Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones, J. Immunol., 140, 4245–4252.
Mosmann, T. R. and Coffman, R. (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol. 7, 145–173.
Finkelman, F. D., Shea-Donohue, T., Goldhill, J., Sullivan, C. A., Morris, S. C., et al. (1997) Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models, Annu. Rev. Immunol., 15, 505–533.
Sadick, M. D., Heinzel, F. P., Shigekane, V. M., Fisher, W. L., and Locksley, R. M. (1987) Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells, J. Immunol., 139, 1303–1309.
Heinzel, F. P., Sadick, M. D., Holaday, B.J., Coffman, R. L., and Locksley, R.M. (1989). Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets, J. Exp. Med., 169, 59–72.
Scott, P., Natovitz, P., Coffman, R.L., Pearce, E., and Sher, A. (1988) Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens, J. Exp. Med., 168, 1675–1684.
Hsieh, C. S., Macatonia, S. E., O’Garra, A., and Murphy, K. M. (1993) Pathogen- induced Th1 phenotype development in CD4+αβ-TCR transgenic T cells is macrophage dependent, Int. Immunol., 5, 371–382.
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes, J. Exp. Med., 170, 827–845.
Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O’Garra, A., and Murphy, K. M. (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages, Science, 260, 547–549.
Seder, R. A., Gazzinelli, R., Sher, A., and Paul, W. E. (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming, Proc. Natl. Acad. Sci. U.S.A., 90, 10188–10192.
Seder, R. A. and Paul, W. E. (1994) Acquisition of lymphokine-producing phenotype by CD4+ T cells, Annu. Rev. Immunol., 12, 635–673.
Murphy, K. M. and Reiner, S. L. (2002) The lineage decisions of helper T cells, Nat. Rev. Immunol., 2, 933–944.
Boulay, J. L., O’Shea, J. J., and Paul, W. E. (2003) Molecular phylogeny within type I cytokines and their cognate receptors, Immunity, 19, 159–163.
Min, B., Prout, M., Hu-Li, J., Zhu, J. F., Jankovic, D., et al. (2004) Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite, J. Exp. Med., 200, 507–517.
Shinkai, K., Mohrs, M., and Locksley, R. M. (2002) Helper T cells regulate type-2 innate immunity in vivo, Nature, 420, 825–829.
Seder, R. A., Plaut, M., Barbieri, S., Urban, J. J., Finkelman, F. D., and Paul, W. E. (1991) Purified Fc εR+ bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a, or ionomycin, J. Immunol., 147, 903–909.
Yoshimoto, T., Bendelac, A., Watson, C., Hu-Li, J., and Paul, W. E. (1995) Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production, Science, 270, 1845-1847.
Voehringer, D., Reese, T., Huang, X., Shinkai, K., and Locksley, R. M. (2006) Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non- eosinophil cells of the innate immune system, J. Exp. Med., 203, 1435–1446.
Yi, J. J. and Gaffen, S. L. (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity, Front. Biosci., 13, 170–177.
Ruddy, M. J., Shen, F., Smith, J., Sharma, A., and Gaffen, S. L. (2004) Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment, J. Leukoc. Biol., 76, 135–144.
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., et al. (2004) Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer binding protein family members, J. Biol. Chem., 279, 2559–2567.
Shen, F., Ruddy, M. J., Plamondon, P., and Gaffen, S. L. (2005) Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells, J. Leukoc. Biol., 77, 388–399.
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., et al. (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, J. Exp. Med., 183, 2593–2603.
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat. Immunol., 6, 1133–1141.
Moseley, T. A., Haudenschild, D. R., Rose, L., and Reddi, A. H. (2003) Interleukin- 17 family and IL-17 receptors, Cytokine Growth Factor Rev., 14, 155–174.
Gaffen, S. L., Kramer, J. M., Yu, J. J., and Shen, F. (2006) The IL-17 cytokine family. In: Vitamins and Hormones (Litwack, G., ed.), Academic Press, London.
Shin, H. C., Benbernou, N., Esnault, S., and Guenounou, M. (1999) Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway, Cytokine, 11, 257–266.
Chabaud, M., Fossiez, F., Taupin, J. L., and Miossec, P. (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines, J. Immunol., 161, 409–414.
Gaffen, S. L. (2005) Biology of recently discovered cytokines: interleukin-17A unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res. Ther., 6(6), 240–247.
Aarvak, T., Chabaud, M., Miossec, P., and Natvig, J. B. (1999) IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells, J. Immunol., 162, 1246–1251.
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., et al. (2007) TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th-17 cell–mediated pathology, Nat. Immunol., 8, 1390–1397.
Steinman, L. (2007) A brief history of T (H)17, the first major revision in the T (H)1/T (H)2 hypothesis of T cell-mediated tissue damage, Nat. Med., 13, 139–145.
Mangan, P. R., Harrington, L. E., O’Quinn, B., Helms, W. S., et al. (2006) Transforming growth factor-beta induces development of the T (H)17 lineage, Nature, 441, 231–234.
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., and Stockinger, B. (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179–189.
Bettelli, E., Carrier, Y., Gao, W., Korn, T., et. al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector T (H)17 and regulatory T cells, Nature, 441, 235–238.
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121–1133.
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat. Immunol., 6, 1123–1132.
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J. Exp. Med., 201, 233–240.
Liang, S. C., Tan, X. Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., and Fouser, L. A. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, J. Exp. Med., 203, 2271–2279.
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., and Dong, C. (2006) Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes, Cell Res., 16, 902–907.
Cua, D. J. and Kastelein, R. A. (2006) TGF-beta, a “double agent” in the immune pathology war, Nat. Immunol., 7, 557–559.
Lockhart, E., Green, A. M., and Flynn, J. L. (2006) IL-17 production is dominated by gamma-delta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection, J. Immunol., 177, 4662–4669.
Shibata, K., Yamada, H., Hara, H., Kishihara, K., and Yoshikai, Y. (2007) Resident V{delta}1+ {gamma} {delta} T cells control early infiltration of neutrophils after Escherichia coli Infection via IL-17 production, J. Immunol., 178, 4466–4472.
Shulze-Koops, H. (2003) The balance of Th1/Th2 cytokines in rheumatoid arthritis, Best Practice 8 Research Clin. Rheumatol., 15(5), 677–691.
Arend, W. P. and Dayer, J. M. (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis, Arthritis Rheum., 38, 151–160.
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., and Palladino, M. A. (1992) Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice, Proc. Natl. Acad. Sci. U.S.A., 89, 7375–7379.
van den Berg, W. B., Joosten, L. A., Helsen, M., and van de Loo, F. A. (1004) Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment, Clin. Exp. Immunol., 95, 237–243.
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., and van den Berg, W. B. (1996) Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNF-α, anti-IL-1α/β, and IL-1Ra, Arthritis Rheum., 39, 797–809.
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., et al. (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium, Arthritis Rheum., 42, 963–970.
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., et al. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism, J. Immunol., 164, 2832–2838.
Koenders, M., Lubberts, E., Joosten, L., Oppers, B., van den Bersselaar, L., Kolls, J., and van den Berg, W. B. (2003) TNF-α dependency of IL-17-induced joint pathology differs under naive and arthritis conditions in vivo, Arthritis Res. Ther., 5(Suppl. 1), 46.
Kehlen, A., Thiele, K., Riemann, D., and Langner, J. (2002) Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis, Clin. Exp. Immunol., 127(3), 539–546.
Chabaud, M., Fossiez, F., Taupin, J. L., and Miossec, P. (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines, J. Immunol., 161, 409–414.
Lubberts, E., Joosten, L. A.B., Oppers, B., van den Bersselaar, L., Coenen-de Roo, C. J. J., Kolls, J. K., et al. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis, J. Immunol., 167, 1004–1013.
Bush, K. A., Farmer, K. M., Walker, J. S., and Kirkham, B.W. (2002) Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein, Arthritis Rheum.., 46, 802–805.
Chabaud, M., Lubberts, E., Joosten, L., van den Berg, W., and Miossec, P. (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis, Arthritis Res., 3, 168–177.
Lubberts, E., Joosten, L. A. B., van de Loo, F. A. J., van den Bersselaar, L. A., and van den Berg, W. B. (2000) Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4, Arthritis Rheum.., 43, 1300–1306.
Martel-Pelletier, J., Mineau, F., Jovanovic, D., Di Battista, J. A., and Pelletier, J. P. (1999) Mitogen-activated protein kinase and nuclear factor κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK), Arthritis Rheum., 42, 2399–2409.
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J. Clin. Invest., 103, 1345–1352.
Lubberts, E., van den Bersselaar, L., Oppers-Walgreen, B., Schwarzenberger, P., Coenen-de Roo, C. J. J., Kolls, J. K., et al. (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance, J. Immunol., 170, 2655–2662.
Cooke, A. (2006) Th17 cells in inflammatory conditions, Rev. Diabet. Stud., 3(2), 72–75.
Bottomly, K. (1988) A functional dichotomy in CD4+ T lymphocytes, Immunol. Today, 9(9), 268–274.
Fehervari, Z. and Sakaguchi, S. (2004) Development and function of CD25+CD4+ regulatory T cells, Curr. Opin. Immunol., 16(2), 203–208.
Fitch, F. W., McKisic, M. D., Lancki, D. W., and Gajewski, T. F. (1993) Differential regulation of murine T lymphocyte subsets, Annu. Rev. Immunol., 11, 29–48.
Fontenot, J. D. and Rudensky, A. Y. (2005) A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3, Nat. Immunol., 6(4), 331–337.
Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U., and Murphy, K. M. (1995) Developmental commitment to the Th2 lineage by extinction of IL-12 signaling, Immunity, 2(6), 665–675.
O’Garra, A. (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets, Immunity, 8(3), 275–283.
Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G., and Wahl, S. M. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J. Exp. Med., 198(12), 1875–1886.
Gorelik, L. and Flavell, R. A. (2002) Transforming growth factor-beta in T-cell biology, Nat. Rev. Immunol., 2(1), 46–53.
Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J., and Gurney, A. L. (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17, J. Biol. Chem., 278(3), 1910–1914.
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J. Exp. Med., 201(2), 233–240.
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., and Cua, D. J. (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation, J. Exp. Med., 198(12), 1951–1957.
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421(6924), 744–748.
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6, J. Clin. Invest., 116(5), 1310–1316.
Shalom-Barak, T., Quach, J., and Lotz, M. (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB, J. Biol. Chem., 273(42), 27467–27473.
Miljkovic, D., Cvetkovic, I., Momcilovic, M., Maksimovic-Ivanic, D., Stosic- Grujicic, S., and Trajkovic, V. (2005) Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells, Cell Mol. Life Sci., 62(22), 2658–2668.
Mensah-Brown, E. P., Shahin, A., Al-Shamisi, M., Wei, X., and Lukic, M. L. (2006) IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin, Eur. J. Immunol., 36(1), 216–223.
Kurusawa, K., Hirose, K., Sano, H., Endo, H., Shinkai, H., Nawata, Y., et al. (2000) Increased interleukin-17 production in patients with systemic sclerosis, Arthritis Rheum., 43, 2455–2463.
Teunissen, M. B., Koomen, C. W., de Waal Malefyt, R., Wierenga, E. A., and Bos, J. D. (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes, J. Invest. Dermatol., 111(4), 645–649.
Albanesi, C., Scarponi, C., Cavani, A., Federici, M., Nasorri, F., and Girolomoni, G. (2000) Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes, J. Invest. Dermatol., 115(1), 81–87.
Eugster, H. P., Frei, K., Kopf, M., Lassmann, H., and Fontana, A. (1998) IL-6- deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis, Eur. J. Immunol., 28(7), 2178–2187.
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis, J. Exp. Med., 187(4), 461–468.
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., et al. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis, Proc. Natl. Acad. Sci. U.S.A., 95(14), 8222–8226.
Okuda, Y., Sakoda, S., Bernard, C. C., Fujimura, H., Saeki, Y., Kishimoto, T., and Yanagihara, T. (1998) IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein, Int. Immunol., 10(5), 703–708.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Georgiev, V.S. (2009). Mammalian Host Defenses: Innate and Adaptive Immunity. In: Georgiev, V.S. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-297-1_38
Download citation
DOI: https://doi.org/10.1007/978-1-60327-297-1_38
Publisher Name: Humana Press
Print ISBN: 978-1-60327-296-4
Online ISBN: 978-1-60327-297-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)